<SEC-DOCUMENT>0001193125-16-675318.txt : 20160808
<SEC-HEADER>0001193125-16-675318.hdr.sgml : 20160808
<ACCEPTANCE-DATETIME>20160808171403
ACCESSION NUMBER:		0001193125-16-675318
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20160808
DATE AS OF CHANGE:		20160808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Wingstop Inc.
		CENTRAL INDEX KEY:			0001636222
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-212393
		FILM NUMBER:		161815152

	BUSINESS ADDRESS:	
		STREET 1:		5501 LBJ FREEWAY
		STREET 2:		5TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75240
		BUSINESS PHONE:		972-331-8484

	MAIL ADDRESS:	
		STREET 1:		5501 LBJ FREEWAY
		STREET 2:		5TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75240

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wingstop, Inc.
		DATE OF NAME CHANGE:	20150323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Wing Stop Holdings Corp
		DATE OF NAME CHANGE:	20150311
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d237680d424b3.htm
<DESCRIPTION>PRELIMINARY PROSPECTUS SUPPLEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Preliminary Prospectus Supplement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3)<BR>Registration Number 333-212393 </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#eb0029"><B>The information in this preliminary prospectus supplement is not
complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
</B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>SUBJECT TO COMPLETION, DATED
AUGUST 8, 2016 </B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRELIMINARY PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>To Prospectus dated July 18, 2016 </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>6,000,000 Shares </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g237680g43q65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement relates to the shares of common stock of Wingstop&nbsp;Inc. being sold by the selling stockholder identified in this prospectus supplement. We will not receive any of the proceeds from the sale of the shares being sold by the selling
stockholder. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on The Nasdaq Global Select Market, or Nasdaq, under the symbol &#147;WING.&#148; We are an
&#147;emerging growth company&#148; as that term is used in the Jumpstart Our Business Startups Act of 2012 and are subject to reduced public company reporting requirements. On August&nbsp;5, 2016, the last reported sale price of our common stock
was $29.80 per share. </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves risks. See &#147;<A HREF="#supprom237680_3">Risk Factors</A>&#148; on page S-3 of this prospectus
supplement, beginning on page 2 of the accompanying prospectus and in our Annual Report on Form 10-K for the fiscal year ended December 26, 2015, or our Annual Report on Form 10-K, filed with the SEC on March 4, 2016, as well as the other
information contained in such Form 10-K (which Form 10-K is incorporated by reference herein) to read about factors you should consider before making a decision to invest in our common stock. </B></P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter
has agreed to purchase the shares of our common stock from the selling stockholder at a price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which will result in $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;of proceeds to the
selling stockholder before expenses. The underwriter proposes to offer the shares of common stock from time to time for sale in one or more transactions on the Nasdaq, in the over-the-counter market, through negotiated transactions or otherwise at
market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. See &#147;Underwriting.&#148; </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter expects to deliver the shares against payment in New York, New York
on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016. </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Barclays
</B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement
dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2016. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="94%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_2">PROSPECTUS SUPPLEMENT SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_3">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_4">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_6">MARKET PRICE OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_7">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_8">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_9">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S.
HOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_10">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_13">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom237680_14">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-24</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="4" ALIGN="center"><B>Prospectus</B></TD>
<TD VALIGN="top"><B>&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_2">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_4">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_6">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_8">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_10">FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_12">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_14">DESCRIPTION OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_16">SELLING STOCKHOLDER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_18">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_20">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_22">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document has two parts, a prospectus supplement and an accompanying prospectus dated July 18, 2016. This prospectus supplement and the
accompanying prospectus are part of a registration statement on Form&nbsp;S-3 that we filed with the Securities and Exchange Commission, or SEC, utilizing a &#147;shelf&#148; registration process. Under this shelf registration process, the selling
stockholders named in a prospectus supplement over time may offer and sell our common stock in one or more offerings or resales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
accompanying prospectus provides you with a general description of our common stock, which the selling stockholder may offer pursuant to this prospectus supplement. This prospectus supplement, which describes certain matters relating to us and the
specific terms of this offering of shares of our common stock, adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference herein.&nbsp;Please carefully read this prospectus supplement, the
accompanying prospectus and any applicable pricing supplement, in addition to the information contained in the documents we refer to under the heading &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Certain Information by
Reference.&#148; If there is any inconsistency between the information in this prospectus supplement and the accompanying prospectus, you should rely on the information in this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Throughout this prospectus, when we use the terms &#147;we,&#148; &#147;us,&#148; &#147;our&#148; and similar terms, we are referring to
Wingstop Inc. and its subsidiaries, collectively, as the context requires. The term &#147;selling stockholder&#148; refers to RC II WS LLC, a Georgia limited liability company, or RC II WS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>We have not authorized anyone to give you any information or to make any representations about our common stock or any offers by our
selling stockholder, other than those contained in this prospectus supplement, the accompanying prospectus or any free writing prospectus prepared by us. If you are given any information or representation about these matters that is not discussed in
this prospectus supplement, the accompanying prospectus or any free writing prospectus, you must not rely on that information. This prospectus supplement and the accompanying prospectus is not an offer to sell anywhere or to anyone where or to whom
the selling stockholder is not permitted to offer to sell securities under applicable law. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The selling stockholder is offering to
sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the common stock in certain
jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of
the common stock and the distribution of this prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an
offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or
solicitation. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should not assume that the information incorporated by reference or provided in this prospectus supplement, the
accompanying prospectus or any free writing prospectus prepared by us is accurate as of any date other than the date on the front cover of those documents. Our business, financial condition, results of operations and prospects may have changed since
that date. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_2"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary does not contain all the information that may be important to purchasers of our common stock. You should carefully
read the entire prospectus supplement, the accompanying prospectus and the financial statements, notes to financial statements and other information incorporated by reference in this prospectus supplement before making any investment decision.
</I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OVERVIEW </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wingstop is a high-growth franchisor and operator of restaurants that offer cooked-to-order, hand-sauced and tossed chicken wings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe we pioneered the concept of wings as a &#147;center-of-the-plate&#148; item for all of our meal occasions. While other concepts
include wings as add-on menu items or focus on wings in a bar or sports-centric setting, we are singularly focused on wings, fries and sides, which generate approximately 90% of our system-wide sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We offer 11 bold, distinctive and craveable flavors on our bone-in and boneless chicken wings paired with hand-cut, seasoned fries and sides
made fresh daily. Our menu is highly-customizable for different dining occasions, and we believe it delivers a compelling value proposition for groups, families, and individuals. We have broad and growing consumer appeal anchored by a sought after
core demographic of 18-34 year old Millennials, which we believe is a loyal consumer group that dines at fast casual restaurants more frequently. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Founded in 1994 in Garland, Texas, we have sold approximately 4 billion wings since our inception. Today, Wingstop is the largest fast casual
chicken wings-focused restaurant chain in the world and has demonstrated strong, consistent growth. As of June 25, 2016, we had a total of 914 restaurants across 39 states and six countries in our system. Our restaurant base is 98% franchised, with
894 franchised locations (including 63 international locations) and 20 company-owned restaurants. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE AND OTHER INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first Wingstop restaurant opened in July 1994. Our operating company, Wingstop Restaurants Inc., was incorporated in November
1996 and began offering franchises for Wingstop restaurants in May 1997. The first franchised restaurant opened in April 1998. On April 9, 2010, Wingstop Holdings, Inc., the holding company for Wingstop Restaurants Inc., was acquired by Wing Stop
Holding Corporation. Wingstop Inc. was incorporated in Delaware on March 18, 2015, as a wholly owned subsidiary of Wing Stop Holding Corporation. On May 28, 2015, Wing Stop Holding Corporation merged with and into Wingstop Inc., with Wingstop Inc.
as the surviving corporation in the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 5501 LBJ Freeway, 5th Floor, Dallas, Texas
75240, and our telephone number at that address is (972) 686-6500. Our website is located at www.wingstop.com. Our website, and the information on our website, is neither part of this prospectus nor incorporated by reference herein. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by the selling stockholder </P></TD>
<TD><BR>6,000,000 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock outstanding after this offering </P></TD>
<TD>28,728,305 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We will not receive any proceeds from the sale of any shares of our common stock offered by the selling stockholder. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should carefully read and consider the information set forth under &#147;Risk Factors&#148; beginning on page S-3 in this prospectus supplement, beginning on page 2 in the accompanying prospectus and in the documents incorporated by
reference herein, including our Annual Report on Form 10-K, before investing in our common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Dividend policy </P></TD>
<TD>We currently expect to retain all future earnings, if any, for use in the operation and expansion of our business. While we recently paid a special dividend to holders of our common stock, we do not anticipate paying cash dividends to holders of
our common stock in the foreseeable future. In addition, our credit agreement restricts our ability to pay dividends. Any determination to pay dividends in the future will be at the discretion of our board of directors and will depend upon, among
other factors, our results of operations, financial condition, capital requirements and covenants in our existing financing arrangements and any future financing arrangements. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">NASDAQ symbol </P></TD>
<TD>&#147;WING.&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the number of shares of our common stock outstanding after this offering
excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,008,904 shares of our common stock issuable upon exercise of outstanding stock options as of June&nbsp;25, 2016 with a weighted average exercise price of $5.24 per share; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,039,727 shares of our common stock reserved for the future issuance, as of June&nbsp;25, 2016, under our 2015 Omnibus Incentive Compensation Plan, or the 2015 Plan. </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>An investment in our common stock involves a high degree of risk. Before making an investment decision, you should carefully consider the
specific risks described under the heading &#147;Risk Factors&#148; in the applicable prospectus supplement and under the caption &#147;Risk Factors&#148; in any of our filings with the SEC pursuant to Sections 13(a), 14 or 15(d) of the Exchange
Act, including, without limitation, our Annual Report on Form 10-K for the year ended December 26, 2015, filed with the SEC on March 4, 2016, which is on file with the SEC and incorporated by reference into this prospectus supplement. If any of
these risks, as well as other risks and uncertainties that are not yet identified or that we currently think are immaterial, actually occur, our business, results of operations or financial condition could be materially and adversely affected. In
such an event, the trading price of our common stock could decline and you could lose part or all of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this
Offering and Ownership of our Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Roark and its affiliates will continue to have significant influence over us after
this offering and may also pursue corporate opportunities independent of us that could present potential conflicts with our and our stockholders&#146; interests. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon consummation of this offering, Roark will beneficially own, in the aggregate, approximately 23.6% of our outstanding common stock. See
&#147;Selling Stockholder&#148; for more information on our beneficial ownership. As a result, Roark will continue to exercise significant influence over all matters requiring stockholder approval, including the election of directors, amendment of
our amended and restated certificate of incorporation and approval of significant corporate transactions and will continue to have significant control over our management and policies. Three of the 7 members of our board of directors are employees
of Roark Capital Management, which is an affiliate of Roark. Roark can take actions that have the effect of delaying or preventing a change of control of us or discouraging others from making tender offers for our shares, which could prevent
stockholders from receiving a premium for their shares. These actions may be taken even if other stockholders oppose them. The concentration of voting power with Roark may have an adverse effect on the price of our common stock. The interests of
Roark may not be consistent with your interests as a stockholder. After the lock-up period expires, Roark will be able to transfer to a third party their common stock, which would not require the approval of our board of directors or our other
stockholders, which would result in a different party having significant influence over us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of
incorporation provides that the doctrine of corporate opportunity does not apply against Roark, or any of our directors who are employees of or affiliated with Roark, in a manner that would prohibit them from investing or participating in competing
businesses. To the extent Roark affiliated funds invest in such other businesses, they may have differing interests than our other stockholders. For example, Roark affiliated funds currently own and may choose to own in the future other restaurant
brands through other investments, which may compete with our brands. Accordingly, the interests of Roark may supersede ours, causing it or its affiliates to compete against us or to pursue opportunities instead of us, for which we have no recourse.
These actions on the part of Roark and inaction on our part could adversely impact our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>We are no longer a &#147;controlled company&#148; within the meaning of the rules of Nasdaq. However, during the phase-in period we may
continue to rely on exemptions from certain corporate governance requirements that provide protection to stockholders of other companies. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were previously a &#147;controlled company&#148; under Nasdaq corporate governance listing standards. As a controlled company, we were
exempt under Nasdaq listing standards from the obligation to comply with certain of Nasdaq&#146;s corporate governance requirements, including the requirements: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">that a majority of our board of directors consist of independent directors, as defined under the rules of Nasdaq; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">that we have a corporate governance and nominating committee that is composed entirely of independent directors with a written charter addressing the committee&#146;s purpose and responsibilities; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">that we have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee&#146;s purpose and responsibilities. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since Roark currently owns less than 50% of the total voting power of our common stock, we are no longer a &#147;controlled company&#148;
within the meaning of the rules of Nasdaq. Under Nasdaq rules, a company that ceases to be a controlled company must comply with the independent board committee requirements as they relate to the nominating and corporate governance and compensation
committees on the following phase-in schedule: (1)&nbsp;one independent committee member at the time it ceases to be a controlled company, (2)&nbsp;a majority of independent committee members within 90 days of the date it ceases to be a controlled
company and (3)&nbsp;all independent committee members within one year of the date it ceases to be a controlled company. Additionally, Nasdaq rules provide a 12-month phase-in period from the date a company ceases to be a controlled company to
comply with the majority independent board requirement. During these phase-in periods, our stockholders will not have the same protections afforded to stockholders of companies of which the majority of directors are independent. Additionally, if,
within the phase-in periods, we are not able to recruit additional directors who would qualify as independent, or otherwise comply with Nasdaq rules, we may be subject to enforcement actions by Nasdaq. Furthermore, a change in our board of directors
and committee membership may result in a change in corporate strategy and operation philosophies, and may result in deviations from our current growth strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price may be volatile or may decline regardless of our operating performance, and you may not be able to resell your shares at
or above the public offering price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock may fluctuate significantly in response to a number of
factors, most of which we cannot control, including those described under &#147;&#151;Risks Related to Our Business&#148; in the section titled &#147;Risk Factors&#148; in our Annual Report on Form 10-K, which is incorporated by reference herein,
and the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential fluctuation in our annual or quarterly operating results; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in capital market conditions that could affect valuations of restaurant companies in general or our goodwill in particular or other adverse economic conditions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in financial estimates by any securities analysts who follow our common stock, our failure to meet these estimates or failure of those analysts to initiate or maintain coverage of our common stock;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">downgrades by any securities analysts who follow our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">future sales of our common stock by our officers, directors and significant stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">global economic, legal and regulatory factors unrelated to our performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">investors&#146; perceptions of our prospects; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements by us or our competitors of significant contracts, acquisitions, joint ventures or capital commitments; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">investor perceptions of the investment opportunity associated with our common stock relative to other investment alternatives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock markets, and in particular Nasdaq, have experienced extreme price and volume fluctuations that have affected and
continue to affect the market prices of equity securities of many food service companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility. If we were involved in securities
litigation, we could incur substantial costs and our resources and the attention of management could be diverted from our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Future sales of our common stock, or the perception in the public markets that these sales
may occur, may depress our stock price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of substantial amounts of our common stock in the public market after this offering,
or the perception that these sales could occur, could adversely affect the price of our common stock and could impair our ability to raise capital through the sale of additional shares. The shares of common stock offered in this offering will be
freely tradable without restriction under the Securities Act, except for any shares of our common stock that may be held or acquired by our directors, executive officers and other affiliates, as that term is defined in the Securities Act, which will
be restricted securities under the Securities Act. Restricted securities may not be sold in the public market unless the sale is registered under the Securities Act or an exemption from registration is available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Roark has the right, subject to certain conditions, to require us to file additional registration statements registering additional shares of
common stock, and Roark and certain other stockholders have the right to require us to include shares of common stock in registration statements that we may file for ourselves or Roark. In order to exercise these registration rights, the holder must
be permitted to sell shares of its common stock under applicable lock-up restrictions described below. Subject to compliance with applicable lock-up restrictions and restrictions under the registration rights agreement (both of which may be waived),
shares of common stock sold under these registration statements can be freely sold in the public market. In the event such registration rights are exercised and a large number of shares of common stock are sold in the public market, such sales could
reduce the trading price of our common stock. These sales also could impede our ability to raise future capital. In addition, we will incur certain expenses in connection with the registration and sale of such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, each of our officers and directors and the selling stockholder have agreed, subject to certain exceptions, with the underwriter not to
dispose of or hedge any of the shares of common stock or securities convertible into or exchangeable for shares of common stock during the period from the date of this prospectus continuing through the date 45&nbsp;days after the date of this
prospectus, except, in our case, for the issuance of common stock upon exercise of options under existing option plans. Barclays Capital Inc. may, in its sole discretion, release any of these shares from these restrictions at any time without
notice. See &#147;Underwriting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of our shares of common stock outstanding as of the date of this prospectus may be sold in the
public market by existing stockholders 45&nbsp;days after the date of this prospectus, subject to applicable volume and other limitations imposed under federal securities laws and subject to the transfer restrictions of certain stockholders set
forth in stock transfer restriction agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in our charter documents and under Delaware law could make
an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may have the effect of delaying or
preventing a change of control or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">authorize our board of directors to issue, without further action by the stockholders, up to 15,000,000 shares of undesignated preferred stock; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">require that, after the investment funds associated with Roark collectively own less than 50% of our outstanding common stock, which we expect to occur after this offering, any action to be taken by our stockholders be
effected at a duly called annual or special meeting and not by written consent; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">specify that special meetings of our stockholders can be called only upon the request of a majority of our board of directors or, at the request of RC II WS so long as RC II WS (or its affiliates) owns at least 10% of
the voting power of all outstanding shares of our common stock; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish that our board of directors is divided into three classes, with each class serving three-year staggered terms; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prohibit cumulative voting in the election of directors. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or
prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management, and
may discourage, delay or prevent a transaction involving a change of control of our company that is in the best interest of our minority stockholders. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect
the prevailing market price of our common stock if they are viewed as discouraging future takeover attempts. In addition, because we are incorporated in Delaware, we have opted out of Section&nbsp;203 of the General Corporation Law of the State of
Delaware, which we refer to as the DGCL, but our amended and restated certificate of incorporation provides that engaging in any of a broad range of business combinations with any &#147;interested&#148; stockholder (any stockholder with 15% or more
of our capital stock) for a period of three years following the date on which the stockholder became an &#147;interested&#148; stockholder is prohibited, subject to certain exceptions. Our amended and restated certificate of incorporation contains
provisions that have the same effect as Section&nbsp;203 of the DGCL, except that they provide RC II WS, any affiliated investment entity and any of their respective direct or indirect transferees of at least 15% of our outstanding common stock and
any group as to which such persons are party to, do not constitute &#147;interested stockholders&#148; for purposes of this provision. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware as the sole and
exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or
employees. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that, unless we consent in writing to an alternative
forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of
our directors, officers and employees to us or our stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws or
(iv)&nbsp;any action asserting a claim that is governed by the internal affairs doctrine, in each case subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein. Any person purchasing or
otherwise acquiring any interest in any shares of our capital stock shall be deemed to have notice of and to have consented to this provision of our amended and restated certificate of incorporation. This choice of forum provision may limit our
stockholders&#146; ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees even though
an action, if successful, might benefit our stockholders. Stockholders who do bring a claim in the Court of Chancery could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Delaware. The Court
of Chancery may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more
favorable to us than to our stockholders. Alternatively, if a court were to find this provision of our amended and restated certificate of incorporation inapplicable to, or unenforceable in respect of, one or more of the specified types of actions
or proceedings, we may incur additional costs which could have a material adverse effect on our business, financial condition or results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>We do not expect to pay any cash dividends for the foreseeable future following this offering. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The continued operation and expansion of our business may require substantial funding. Accordingly, we do not anticipate that we will pay any
cash dividends on shares of our common stock for the foreseeable future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
following this offering. Any determination to pay dividends in the future will be at the discretion of our board of directors and will depend upon results of operations, financial condition,
contractual restrictions, including our senior secured credit facility and other indebtedness we may incur, restrictions imposed by applicable law and other factors our board of directors deems relevant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>If securities analysts or industry analysts downgrade our shares, publish negative research or reports, or cease to publish reports
about our business, our share price and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our common stock is influenced by the
research and reports that industry or securities analysts publish about us, our business and our industry. If one or more analysts adversely change their recommendation regarding our shares or our competitors&#146; stock, our share price would
likely decline. If one or more analysts cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our share price or trading volume to decline. As a result, the
market price for our common stock may decline below the offering price and you might not be able to resell your shares of our common stock at or above the offering price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_4"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the documents incorporated by reference in this prospectus supplement contain statements about future events
and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of our future financial and operating performance and growth plans, taking into account the information
currently available to us. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express
or imply in any forward-looking statements and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">overall macroeconomic conditions may impact our ability to successfully execute our growth strategy and franchise and open new restaurants that are profitable and to increase our revenue and operating profits;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of the operating results of our and our franchisees&#146; existing restaurants on our financial performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of new restaurant openings on our financial performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to recruit and contract with qualified franchisees and to open new franchise restaurants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to develop and maintain the Wingstop brand, including through effective advertising and marketing and the support of our franchisees&#146; and the negative impact of actions of a franchisee, acting as an
independent third party, could have on our financial performance or brand; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">concerns regarding food safety and food-borne illness and other health concerns; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our and our franchisees&#146; reliance on vendors, suppliers and distributors or changes in food and supply costs, including any increase in the prices of the ingredients most critical to our menu, particularly bone-in
chicken wings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our and our franchisees&#146; ability to compete with many other restaurants and to increase domestic same store sales and average weekly sales; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to successfully meet or exceed the expectations of securities analysts or investors concerning our annual or quarterly operating results, domestic same store sales or average weekly sales; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expansion into new markets may present increased risks due to our unfamiliarity with those areas; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the reliability of our, our franchisees&#146; and our licensees&#146; information technology systems and network security, including costs resulting from breaches of security of confidential guest, franchisee or
employee information; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">legal complaints, litigation or regulatory compliance, including changes in laws impacting the franchise business model; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our and our franchisees&#146; ability to attract and retain qualified employees while also controlling labor costs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">publicity regarding other franchisors controlled by Roark; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential fluctuations in our annual or quarterly operating results and the impact of significant adverse weather conditions and other disasters; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disruptions in our and our franchisees&#146; ability to utilize computer systems to process transactions and manage our business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">health concerns arising from outbreaks of viruses, including the impact of a pandemic spread of avian flu on our and our franchisees&#146; supply of chicken; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our and our franchisees&#146; ability to obtain and maintain required licenses and permits or to comply with alcoholic beverage or food control regulations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to maintain insurance that provides adequate levels of coverage against claims; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our and our franchisees&#146; ability to successfully operate in unfamiliar markets and markets where there may be limited or no market recognition of our brand, including the impact that our expansion into
international markets has on our exposure to risk factors over which neither we nor our franchisees have control; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the potential impact opening new restaurants in existing markets could have on sales at existing restaurants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effectiveness of our advertising and marketing campaigns, which may not be successful; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">food safety issues, which may adversely impact our or our franchisees&#146; business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in consumer preferences, including changes caused by diet and health concerns or government regulation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the continued service of our executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to successfully open new franchised Wingstop restaurants for which we have signed commitments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our stated sales to investment ratio and average unlevered cash-on-cash return may not be indicative of future results of any new franchised restaurant; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to protect our intellectual property; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to generate or raise capital on acceptable terms in the future, including our ability to incur additional debt and other restrictions under the terms of our existing senior secured credit facility;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the JOBS Act allowing us to postpone the date by which we must comply with certain laws and regulations intended to protect investors and to reduce the amount of information we provide in our reports filed with the SEC;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs and time requirements as a result of operating as a public company, including our ability to effectively remediate identified material weaknesses and improve internal control over financial reporting in order
to comply with applicable reporting obligations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuations in exchange rates on our revenue; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">future impairment charges; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the concentration of ownership by our principal stockholder; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the loss of our &#147;controlled company&#148; exemptions under Nasdaq listing standards; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of anti-takeover provisions in our charter documents and under Delaware law, which could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current
management and limit the market price of our common stock. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Words such as &#147;anticipates,&#148; &#147;believes,&#148;
&#147;continues,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;goal,&#148; &#147;objectives,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;opportunity,&#148; &#147;plans,&#148; &#147;potential,&#148; &#147;near-term,&#148;
&#147;long-term,&#148; &#147;projections,&#148; &#147;assumptions,&#148; &#147;projects,&#148; &#147;guidance,&#148; &#147;forecasts,&#148; &#147;outlook,&#148; &#147;target,&#148; &#147;trends,&#148; &#147;should,&#148; &#147;could,&#148;
&#147;would,&#148; &#147;will&#148; and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements included or incorporated by reference in this prospectus supplement entirely by our risk
factors and other cautionary factors included or incorporated by reference into this prospectus supplement which could cause our actual results to differ materially from those projected in any forward-looking statements we make. We assume no
obligation to update or revise these forward-looking statements included or incorporated by reference in this prospectus supplement for any reason, or to update the reasons actual results could differ materially from those anticipated in these
forward-looking statements, even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder will receive all of the proceeds offered by this prospectus supplement. We will not receive any proceeds from the sale
of shares of our common stock by the selling stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_6"></A>MARKET PRICE OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock has been listed on Nasdaq under the symbol &#147;WING&#148; since June 12, 2015. Before then, there was no public market for
our common stock. On August 5, 2016, the last reported sales price of our common stock was $29.80. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth, for
the period indicated, the high and low sales prices of our common stock as reported by Nasdaq. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:22.65pt; font-size:8pt; font-family:Times New Roman"><B>Period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2016:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Quarter (through August 5, 2016)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26.42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2015:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Quarter (from June 12, 2015)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August 5, 2016, we had approximately 19 holders of record of our common stock. The actual number of
stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal years 2015, 2013 and 2012, we paid cash dividends in the aggregate amounts of $48.0 million, $38.5 million and $19.3
million, respectively, to our stockholders. In addition, on July 15, 2016, we paid a special cash dividend of $2.90 per share, an aggregate payment of approximately $83.2 million, to holders of our common stock of record as of July 12, 2016.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently intend to retain all available funds and any future earnings to fund the development and growth of our business and to repay
indebtedness. While we recently paid a special dividend to holders of our common stock, we do not anticipate paying cash dividends to holders of our common stock in the foreseeable future. Additionally, our ability to pay dividends on our common
stock is limited by restrictions on the ability of our subsidiaries and us to pay dividends or make distributions to us under the terms of the agreements governing our indebtedness. Any future determination to pay dividends will be at the discretion
of our board of directors, subject to compliance with covenants in current and future agreements governing our indebtedness, and will depend upon our results of operations, financial condition, capital requirements and other factors that our board
of directors deems relevant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, you may need to sell your shares of our common stock to realize a return on your investment,
and you may not be able to sell your shares at or above the price you paid for them. See &#147;Risk Factors&#151;Risks Related to this Offering and Ownership of our Common Stock&#151;We do not expect to pay any cash dividends for the foreseeable
future following this offering.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_8"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth information with respect to the beneficial ownership of our shares of common stock held by the selling stockholder
as of August&nbsp;5, 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership for the purposes of the following table is determined in accordance with the rules and
regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof or has the right
to acquire such powers within 60 days. Percentage of beneficial ownership is based on 28,728,305 shares of common stock outstanding as of August&nbsp;5, 2016. Except as disclosed in the footnotes to this table and subject to applicable community
property laws, we believe that the selling stockholder identified in the table possesses sole voting and investment power over all shares of common stock shown as beneficially owned by the selling stockholder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B><br><B>Beneficially&nbsp;Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of&nbsp;Shares</B><br><B>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares&nbsp;to&nbsp;be</B><br><B>Sold in</B><br><B>The&nbsp;Offering</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before</B><br><B>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Principal and Selling Stockholder:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RC II WS LLC (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,765,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6,765,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">44.4%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">23.6%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">RC II WS LLC directly owns 12,765,858 shares of common stock. RC II WS LLC, a Georgia limited liability company, is controlled by Roark Capital Partners II, LP, a Delaware limited partnership. Roark Capital Partners II,
LP is controlled by its general partner, Roark Capital GenPar II, LLC, a Delaware limited liability company, which is in turn controlled by its managing member, Neal K. Aronson, who has served as chairman of our board of directors since February
2015 and&nbsp;served as a member of our compensation committee through May 18, 2016. Each of Roark Capital Partners II, LP, Roark Capital GenPar II, LLC and Mr. Aronson may be deemed to have voting and dispositive power with respect to the common
stock directly owned by RC II WS LLC and therefore be deemed to be the beneficial owner of the common stock held by RC II WS LLC, but each disclaim beneficial ownership of such common stock. The principal business address of each of the entities and
persons identified in this paragraph is c/o Roark Capital Management, LLC, 1180 Peachtree Street, Suite 2500, Atlanta, GA, 30309. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_9"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a
summary of the material U.S. federal income tax consequences of the purchase, ownership and disposition of our common stock to a non-U.S. holder that purchases shares of our common stock in this offering. For purposes of this summary, a
&#147;non-U.S. holder&#148; means a beneficial owner of our common stock that is not a &#147;U.S. person&#148; or a partnership for U.S. federal income tax purposes. A U.S. person is any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an individual citizen or resident of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States, any state thereof or the District of Columbia; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an estate the income of which is subject to U.S. federal income tax regardless of its source; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a trust (1)&nbsp;whose administration is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or
(2)&nbsp;that has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person for U.S. federal income tax purposes. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of a holder that is classified as a partnership for U.S. federal income tax purposes, the tax treatment of a partner in such
partnership generally will depend upon the status of the partner and the activities of the partnership. If you are a partner in a partnership holding our common stock, then you should consult your own tax advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based upon the provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, the Treasury
regulations promulgated thereunder and administrative and judicial interpretations thereof, all as of the date hereof. Those authorities may be changed, perhaps retroactively, so as to result in U.S. federal income tax consequences different from
those summarized below. We cannot assure you that a change in law, possibly with retroactive application, will not alter significantly the tax consequences described in this summary. We have not sought and do not plan to seek any ruling from the
U.S. Internal Revenue Service, which we refer to as the IRS, with respect to the statements and conclusions set forth in the following summary, and there can be no assurance that the IRS or a court will agree with such statements and conclusions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary does not address all aspects of U.S. federal income taxes that may be relevant to non-U.S. holders in light of their
personal circumstances, and does not address federal taxes other than the U.S. federal income tax, or address state, local or non-U.S. tax considerations. Special rules, not discussed here, may apply to certain non-U.S. holders, including (without
limitation): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">U.S. expatriates or former citizens or long-term residents of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">controlled foreign corporations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">passive foreign investment companies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pass-through entities (or investors in such entities) that are subject to special treatment under the Code. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such non-U.S. holders should consult their own tax advisors to determine the U.S. federal, state, local and other tax consequences that may be
relevant to them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary applies only to a non-U.S. holder that holds our common stock as a capital asset (within the meaning of
Section&nbsp;1221 of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are considering the purchase of our common stock, you should consult your own tax advisor
concerning the particular U.S. federal income tax consequences to you of the purchase, ownership and disposition of our common stock, as well as the consequences to you arising under U.S. tax laws other than the federal income tax laws or under the
laws of any other taxing jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed under the section entitled &#147;Dividend Policy&#148; above, we do not currently anticipate paying any dividends to holders of
our common stock in the foreseeable future. If we make a distribution of cash or property (other than certain distributions of our common stock) with respect to our common stock (or complete a redemption that is treated as a distribution with
respect to our common stock), such distribution will be treated as a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits (as determined under U.S. federal income tax principles).
Dividends paid to you generally will be subject to withholding of U.S. federal income tax at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty) of the gross amount of the dividends. However, dividends that are
effectively connected with the conduct of a trade or business by you within the United States and, in cases in which certain tax treaties require, are attributable to a U.S. permanent establishment maintained by you, are not subject to the
withholding tax, but instead are subject to U.S. federal income tax on a net income basis at applicable graduated individual or corporate rates. Certain certification and disclosure requirements including delivery of a properly executed IRS
Form&nbsp;W-8ECI must be satisfied for effectively connected income to be exempt from U.S. federal withholding tax. Any such effectively connected dividends received by a foreign corporation may also be subject to a &#147;branch profits tax&#148; at
a 30% rate or such lower rate as may be specified by an applicable income tax treaty. Non-U.S. holders should consult their tax advisors regarding applicable tax treaties that may provide for different rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the amount of a distribution paid on our common stock exceeds our current and accumulated earnings and profits, such excess will be
allocated ratably among each share of common stock with respect to which the distribution is paid and treated first as a tax-free return of capital to the extent of your adjusted tax basis in each such share, and thereafter as capital gain from a
sale or other taxable disposition of such share of common stock that is taxed to you as described below under the heading &#147;Gain on Disposition of Common Stock.&#148; Your adjusted tax basis in a share of our common stock is generally the
purchase price of such share, reduced by the amount of any such tax-free returns of capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you wish to claim the benefit of an
applicable income tax treaty to avoid or reduce withholding of U.S. federal income tax on dividends, then you must (i)&nbsp;provide the withholding agent with a properly completed IRS Form&nbsp;W-8BEN or W-8BEN-E (or other applicable form) and
certify under penalties of perjury that you are not a U.S. person and are eligible for treaty benefits, or (ii)&nbsp;if you hold our common stock through certain foreign intermediaries (including partnerships), satisfy the relevant certification
requirements of applicable U.S. Treasury regulations by providing appropriate documentation to the intermediaries (which then will be required to provide certification to the applicable withholding agent, either directly or through other
intermediaries). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are eligible for a reduced rate of U.S. federal income tax pursuant to an income tax treaty, then you may obtain
a refund or credit of any excess amounts withheld by timely filing an appropriate claim with the IRS. You should consult your tax advisor regarding your entitlement to benefits under any applicable income tax treaty. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Disposition of Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
generally will not be subject to U.S. federal income tax with respect to gain realized on the sale or other taxable disposition of our common stock (other than a redemption that is treated as a distribution for U.S. federal income tax purposes and
taxed as described above), unless: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the gain is effectively connected with a trade or business you conduct in the United States, and, in cases in which certain tax treaties require, is attributable to a U.S. permanent establishment maintained by you;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if you are an individual, you are present in the United States for 183&nbsp;days or more in the taxable year of the sale or other taxable disposition, and you have a &#147;tax home&#148; (as defined in the Code) in the
United States; or </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we are or have been a &#147;United States real property holding corporation&#148; for U.S. federal income tax purposes at any time within the shorter of (i)&nbsp;the five-year period ending on the date of the sale or
other taxable disposition of our common stock and (ii)&nbsp;your holding period for our common stock. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a non-U.S.
holder described in the first bullet point above, you generally will be subject to tax on the net gain derived from the disposition under regular graduated U.S. federal income tax rates. If you are a foreign corporation described in the first bullet
point above, you may also be subject to a branch profits tax equal to 30% of your effectively connected earnings and profits or such lower rate as may be specified by an applicable income tax treaty. If you are an individual described in the second
bullet point above, you will generally be subject to a flat 30% (or such lower rate as may be specified by an applicable income tax treaty) tax on the gain derived from the disposition, which may be offset by certain U.S. source capital losses (even
though you are not considered a resident of the United States) but may not be offset by any capital loss carryovers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the
third bullet point above, we believe that we are not currently, and we do not anticipate becoming, a United States real property holding corporation. However, because the determination of whether we are a United States real property holding
corporation depends on the fair market value of our United States real property interests relative to the fair market value of our global real property interests and other business assets, there can be no assurance that we are not a United States
real property holding corporation and will not become one in the future. In the event we do become a United States real property holding corporation, as long as our common stock is regularly traded on an established securities market, gain on a sale
or disposition of our common stock will generally be subject to taxation pursuant to the third bullet point above only if you actually or constructively held more than 5% of our common stock at any time during the shorter of (i)&nbsp;the five-year
period ending on the date of the sale or disposition of our common stock or (ii)&nbsp;your holding period for our common stock. If gain on the sale or other taxable disposition of our common stock were subject to taxation under the third bullet
point above, you would be subject to regular U.S. federal income tax with respect to such gain in generally the same manner as a U.S. person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should consult your tax advisor regarding potentially applicable income tax treaties that provide for different rules. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding Tax </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must report annually to the IRS and to you the amount of dividends paid to you and the amount of tax, if any, withheld with respect to such
dividends. The IRS may make this information available to the tax authorities in the country in which you are resident. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, you
may be subject to information reporting requirements and backup withholding (currently at a rate of 28%) with respect to dividends paid on, and the proceeds from the disposition of, shares of our common stock, unless, generally, you certify to the
withholding agent under penalties of perjury (usually on IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN&nbsp;or</FONT> W-8BEN-E) that you are not a U.S. person or you otherwise establish an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement
to the tax authorities of the country in which you reside (or are established). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts
withheld under the backup withholding rules may be allowed as a refund or a credit against your U.S. federal income tax liability, provided the required information is timely furnished by you to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Withholding Tax </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code (commonly referred to as &#147;FATCA&#148;) generally will impose a 30% withholding tax on dividends
paid on our common stock and, beginning after December&nbsp;31, 2018, gross proceeds from the sale or other disposition of our common stock, in each case if the common stock is held by or through: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">certain foreign financial institutions (including investment funds), unless the institution otherwise qualifies for an exemption or enters into an agreement with the U.S. Treasury (i)&nbsp;to collect and report, on an
annual basis, information with respect to accounts in the institution held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons, and (ii)&nbsp;to withhold 30% on certain payments; or
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a non-financial non-U.S. entity, unless the entity (i)&nbsp;either certifies to the applicable withholding agent or the IRS that the entity does not have any &#147;substantial United States owners&#148; or provides
certain information regarding the entity&#146;s &#147;substantial United States owners&#148; or (ii)&nbsp;otherwise establishes an exemption from such withholding tax. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rules described above may be modified by an intergovernmental agreement entered into between the United States and an applicable foreign
country, or by future Treasury regulations or other guidance. Non-U.S. holders are encouraged to consult their tax advisors regarding the possible implications of these rules on their investment in our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>POTENTIAL PURCHASERS OF OUR COMMON STOCK ARE URGED TO CONSULT THEIR OWN TAX ADVISORS TO DETERMINE THE U.S. FEDERAL, STATE, LOCAL AND
NON-U.S. TAX CONSIDERATIONS OF PURCHASING, OWNING AND DISPOSING OF OUR COMMON STOCK. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_10"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. is acting as underwriter of the offering. Subject to the terms and conditions set forth in an underwriting agreement
between us, the selling stockholder and the underwriter, the selling stockholder has agreed to sell to the underwriter, and the underwriter has agreed to purchase from the selling stockholder 6,000,000 shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the underwriter has agreed to purchase all of the shares sold
under the underwriting agreement if any of these shares are purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the selling stockholder have agreed to indemnify the
underwriter against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriter may be required to make in respect of those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter is offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal
matters by their counsel, including the validity of the shares, and other conditions contained in the underwriting agreement, such as the receipt by the underwriter of officer&#146;s certificates and legal opinions. The underwriter reserves the
right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Discounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter is purchasing the shares of common stock from the selling stockholder at $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per
share (representing approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;aggregate proceeds to the selling stockholder, before expenses). The underwriter may offer the shares of common stock from time to time for sale in one or more
transactions on the Nasdaq, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. In connection with the
sale of the shares of common stock offered hereby, the underwriter may be deemed to have received compensation in the form of underwriting discounts. The underwriter may effect such transactions by selling shares of common stock to or through
dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriter and / or purchasers of shares of common stock for whom they may act as agents or to whom they may sell as principal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expenses of the offering, not including the underwriting discounts, are estimated at
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and are payable by us. We have agreed to reimburse the underwriter for expenses relating to clearing of this offering with FINRA in an amount up to $30,000. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, our
executive officers and directors and the selling stockholder have agreed not to sell or transfer any common stock or securities convertible into, exchangeable for, exercisable for, or repayable with common stock, for 45 days after the date of this
prospectus supplement, with certain limited exceptions, without first obtaining the written consent of the underwriter. This lock-up provision applies to common stock and to securities convertible into or exchangeable or exercisable for or repayable
with common stock. It also applies to common stock owned now or acquired later by the person executing the agreement or for which the person executing the agreement later acquires the power of disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares are listed on the Nasdaq under the symbol &#147;WING.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Short Positions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
offering, the underwriter may purchase and sell our common stock in the open market. These transactions may include short sales and purchases on the open market to cover positions created </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by short sales. Short sales involve the sale by the underwriter of a greater number of shares than they are required to purchase in the offering. &#147;Covered&#148; short sales are sales made in
an amount not greater than the underwriter&#146;s option to purchase additional shares described above. The underwriter may close out any covered short position by either exercising their option to purchase additional shares or purchasing shares in
the open market. In determining the source of shares to close out the covered short position, the underwriter will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may
purchase shares through the option granted to them. &#147;Naked&#148; short sales are sales in excess of such option. The underwriter must close out any naked short position by purchasing shares in the open market. A naked short position is more
likely to be created if the underwriter is concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriter&#146;s purchases to cover the syndicate short sales may have the effect of raising or
maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The
underwriter may conduct these transactions on Nasdaq, in the over-the-counter market or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of us, the selling stockholder or
the underwriter make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common stock. In addition, neither we, the selling stockholder nor the
underwriter make any representation that the underwriter will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Passive Market Making </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with
this offering, the underwriter may engage in passive market making transactions in the common stock on the Nasdaq in accordance with Rule 103 of Regulation M under the Exchange Act during a period before the commencement of offers or sales of common
stock and extending through the completion of distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below the passive market
maker&#146;s bid, that bid must then be lowered when specified purchase limits are exceeded. Passive market making may cause the price of our common stock to be higher than the price that otherwise would exist in the open market in the absence of
those transactions. The underwriter is not required to engage in passive market making and may end passive market making activities at any time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection
with the offering, the underwriter may distribute prospectuses by electronic means, such as e-mail. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriter and its affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the
ordinary course of business with us or our affiliates. The underwriter has received, or may in the future receive, customary fees and commissions for these transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of its business activities, the underwriter and its affiliates may make or hold a broad array of
investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities activities
may involve securities and/or instruments of ours or our affiliates. The underwriter and its affiliates may also make investment recommendations and/or publish or express independent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Economic Area
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area, no offer of ordinary shares which are the subject of the offering has been, or
will be made to the public in that Member State, other than under the following exemptions under the Prospectus Directive: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) to any
legal entity which is a qualified investor as defined in the Prospectus Directive; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) to fewer than 150 natural or legal persons (other
than qualified investors as defined in the Prospectus Directive), subject to obtaining the prior consent of the Representatives for any such offer; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) in any other circumstances falling within Article 3(2) of the Prospectus Directive, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I> that no such offer of ordinary shares referred to in (a) to (c) above shall result in a requirement for the Company or any Representative to
publish a prospectus pursuant to Article 3 of the Prospectus Directive, or supplement a prospectus pursuant to Article 16 of the Prospectus Directive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person located in a Member State to whom any offer of ordinary shares is made or who receives any communication in respect of an offer of
ordinary shares, or who initially acquires any ordinary shares will be deemed to have represented, warranted, acknowledged and agreed to and with each Representative and the Company that (1) it is a &#147;qualified investor&#148; within the meaning
of the law in that Member State implementing Article 2(1)(e) of the Prospectus Directive; and (2) in the case of any ordinary shares acquired by it as a financial intermediary as that term is used in Article 3(2) of the Prospectus Directive, the
ordinary shares acquired by it in the offer have not been acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Member State other than qualified investors, as that term is defined in the
Prospectus Directive, or in circumstances in which the prior consent of the Representatives has been given to the offer or resale; or where ordinary shares have been acquired by it on behalf of persons in any Member State other than qualified
investors, the offer of those ordinary shares to it is not treated under the Prospectus Directive as having been made to such persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, our representatives and their respective affiliates will rely upon the truth and accuracy of the foregoing representations,
acknowledgments and agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement has been prepared on the basis that any offer of shares in any Member State
will be made pursuant to an exemption under the Prospectus Directive from the requirement to publish a prospectus for offers of shares. Accordingly any person making or intending to make an offer in that Member State of shares which are the subject
of the offering contemplated in this prospectus may only do so in circumstances in which no obligation arises for the Company or any of the Representatives to publish a prospectus pursuant to Article 3 of the Prospectus Directive in relation to such
offer. Neither the Company nor the Representatives have authorized, nor do they authorize, the making of any offer of shares in circumstances in which an obligation arises for the Company or the Representatives to publish a prospectus for such
offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer of ordinary shares to the public&#148; in relation to any
ordinary shares in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and the ordinary shares to be offered so as to enable an investor to decide to purchase or subscribe the
ordinary shares, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression &#147;Prospectus Directive&#148; means Directive 2003/71/EC (as amended) and includes any
relevant implementing measure in each Member State. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may
only be directed at persons who are &#147;qualified investors&#148; (as defined in the Prospectus Directive) (i) who have professional experience in matters relating to investments falling within Article 19 (5) of the Financial Services and Markets
Act 2000 (Financial Promotion) Order 2005, as amended (the &#147;Order&#148;) and/or (ii) who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (d) of the Order (all such
persons together being referred to as &#147;relevant persons&#148;). This document must not be acted on or relied on in the United Kingdom by persons who are not relevant persons. In the United Kingdom, any investment or investment activity to which
this document relates is only available to, and will be engaged in with, relevant persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Switzerland </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;) or on any other stock
exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for
listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares
or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this document nor any other
offering or marketing material relating to the offering, the Company, the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be
supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection
afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective
Investors in the Dubai International Financial Centre </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement relates to an Exempt Offer in accordance with the
Offered Securities Rules of the Dubai Financial Services Authority (&#147;DFSA&#148;). This prospectus supplement is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered
to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth
herein and has no responsibility for the prospectus supplement. The shares to which this prospectus supplement relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their
own due diligence on the shares. If you do not understand the contents of this prospectus supplement you should consult an authorized financial advisor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Australia </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and
Investments Commission (&#147;ASIC&#148;), in relation to the offering. This prospectus supplement does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the &#147;Corporations
Act&#148;), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any offer in Australia of the shares may only be made to persons (the &#147;Exempt Investors&#148;) who are &#147;sophisticated
investors&#148; (within the meaning of section 708(8) of the Corporations Act), &#147;professional </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investors&#148; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section 708 of the Corporations Act so that it is
lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares applied for by Exempt
Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be
required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such
Australian on-sale restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement contains general information only and does not take account of the investment
objectives, financial situation or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in
this prospectus supplement is appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice
to Prospective Investors in Hong Kong </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock have not been offered or sold and will not be offered or sold in Hong
Kong, by means of any document, other than (a) to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b) in other circumstances which do not
result in the document being a &#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document
relating to the shares of common stock have been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be
accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares of common stock which are or are intended to be disposed of only to persons outside Hong Kong or
only to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance and any rules made under that Ordinance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to
Prospective Investors in Japan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered under the Financial Instruments and Exchange Law of
Japan (Law No. 25 of 1948, as amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for re-offering or resale, directly or indirectly, in Japan or to any
Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph,
&#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Singapore </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus
supplement and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an
invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#147;SFA&#148;), (ii) to
a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275, of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other
applicable provision of the SFA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased under Section 275 of the SFA by a relevant person
which is: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to
hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">securities (as defined in Section 239(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust
shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section 275 of the SFA except: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred
to in Section 275(1A) or Section 276(4)(i)(B) of the SFA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) where no consideration is or will be given for the transfer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) where the transfer is by operation of law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d) as specified in Section 276(7) of the SFA; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e) as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument 45-106 <I>Prospectus Exemptions</I> or subsection 73.3(1) of the <I>Securities Act</I> (Ontario), and are permitted clients, as defined in National Instrument 31-103 <I>Registration Requirements, Exemptions and
Ongoing Registrant Obligations</I> . Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this
prospectus supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the
purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4)
of National Instrument 33-105 <I>Underwriting Conflicts</I> (<B>NI 33-105</B>), the underwriter is not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T</B>he validity of the shares of common stock being offered by this prospectus will be passed upon for us by our counsel, King&nbsp;&amp;
Spalding LLP. The underwriter has been represented in this offering by Latham&nbsp;
&amp; Watkins LLP, New York, New York. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Wingstop Inc. and subsidiaries at December 26, 2015 and December 27, 2014 and for each of the three
fiscal years in the period ended December 26, 2015 incorporated by reference in this Prospectus and Registration Statement have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report
thereon incorporated by reference herein, and are incorporated by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_13"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; into this prospectus supplement the information we file with it. This means that we
can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus supplement, and later information that we file with the SEC will automatically
update and supersede this information. We incorporate by reference the documents listed below and any future filings made with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange
Act; provided, however, that we are not incorporating by reference any information furnished (but not filed) under Item 2.02 or Item 7.01 of any Current Report on Form 8-K: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">our annual report on Form 10-K for the year ended December 26, 2015, filed on March 4, 2016 (including information specifically incorporated by reference into our Form 10-K from our definitive proxy statement relating
to our 2016 annual meeting of stockholders, filed on March 22, 2016); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">our quarterly reports on Form 10-Q for the thirteen weeks ended March 26, 2016, filed on May 6, 2016 and the thirteen weeks ended June 25, 2016, filed on August 5, 2016; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">our current reports on Form 8-K filed on May 5, 2016 (Item 5.07 only), May 20, 2016, June 30, 2016 and July 6, 2016; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">the description of our common stock contained in our Registration Statement on Form 8-A filed on June 11, 2015, including any amendment or report filed for the purpose of updating such description. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may obtain any of the documents incorporated by reference in this prospectus from the SEC through the SEC&#146;s website at the address
provided above. You may also request and we will provide, free of charge, a copy of any document incorporated by reference in this prospectus (excluding exhibits to such document unless an exhibit is specifically incorporated by reference in the
document) by visiting our internet website at www.wingstop.com or by writing or calling us at the following address and telephone number: Wingstop Inc., Corporate Secretary, 5501 LBJ Freeway, 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>
Floor, Dallas, Texas 75240, telephone (972) 686-6500. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom237680_14"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form&nbsp;S-3 under the Securities Act with respect to the common stock offered by this
prospectus supplement. This prospectus supplement does not contain all the information set forth in the registration statement and its exhibits and schedules, portions of which have been omitted as permitted by the rules and regulations of the SEC.
For further information about us, as well as our common stock, we refer you to the registration statement and to its exhibits and schedules. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we file annual, quarterly and current reports, proxy and information statements and
other information with the SEC. Our SEC filings, including the registration statement, are available to the public from the SEC&#146;s website at http://www.sec.gov. To receive copies of public records not posted to the SEC&#146;s website at
prescribed rates, you may complete an online form at http://www.sec.gov, send a fax to (202)&nbsp;772-9337 or submit a written request to the SEC, Office of FOIA/PA Operations, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at
1-800-SEC-0330 for further information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also make available free of charge on our website, www.wingstop.com, under &#147;Investor
Relations/Financials/SEC Filings,&#148; all materials that we file electronically with the SEC, including our annual reports on Form&nbsp;10-K, quarterly reports on Form&nbsp;10-Q, current reports on Form&nbsp;8-K, Section&nbsp;16 reports and
amendments to those reports as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC. Information contained on our website or any other website is not incorporated by reference into this
prospectus supplement and does not constitute a part of this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>12,765,858 shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g237680g43q65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling
stockholder identified in this prospectus may offer and sell, from time to time, in one or more offerings, up to 12,765,858 shares of our common stock, at prices and on terms that will be determined at the time of the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates solely to sales of our common stock by the selling stockholder identified in this prospectus. We are not selling any
common stock under this prospectus and will not receive any of the proceeds from the sale of the common stock by the selling stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus describes the general manner in which the shares of our common stock may be offered and sold by the selling stockholder. Each
time securities are offered pursuant to this prospectus, we may provide a prospectus supplement and attach it to this prospectus. Any prospectus supplement will contain specific information about the terms of the offering and the offered securities
and may also add, update or change the information in this prospectus. You should read this prospectus and any applicable prospectus supplement carefully before you invest in our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of our common stock may be sold at fixed prices, prevailing market prices at the times of sale, prices related to the prevailing
market prices, varying prices determined at the times of sale or negotiated prices. The shares of our common stock offered by this prospectus and any accompanying prospectus supplement may be offered by the selling stockholder directly to investors
or to or through underwriters, dealers or other agents. The prospectus supplement for each offering will describe in detail the plan of distribution for that offering and will set forth the names of any underwriters, dealers or agents involved in
the offering and any applicable fees, commissions or discount arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on the NASDAQ Global Select Market
under the symbol &#147;WING.&#148; We are an &#147;emerging growth company&#148; as that term is used in the Jumpstart Our Business Startups Act of 2012 and are subject to reduced public company reporting requirements. On July&nbsp;15, 2016, the
last reported sale price of our common stock was $25.73 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves risks. See &#147;<A HREF="#toc237680_8">Risk
 Factors</A>&#148; on page&nbsp;2 of this prospectus and any risk factors described in any applicable prospectus supplement and in the documents we incorporate by reference.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus is July&nbsp;18, 2016 </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_2">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_4">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_6">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_8">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_10">Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_12">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_14">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_16">Selling Stockholder</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_18">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_20">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc237680_22">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_2"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a shelf registration statement that we have filed with the Securities and Exchange Commission, or SEC, under the
Securities Act of 1933, as amended, or the Securities Act. By using a shelf registration statement, the selling stockholder identified in this prospectus may sell shares of our common stock in one or more offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus provides you with a general description of the common stock the selling stockholder may offer. Each time the selling
stockholder sells shares of our common stock under this shelf registration process, we may provide a prospectus supplement that contains specific information about the terms of that offering. Any prospectus supplement may add, update or change
information contained in this prospectus. If there is any inconsistency between the information in this prospectus and any applicable prospectus supplement, you should rely on the information in the prospectus supplement. You should read both this
prospectus and any prospectus supplement together with the additional information described below in the section entitled &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also prepare free writing prospectuses to describe the terms of particular sales of our common stock by the selling stockholder, which
terms may vary from those described in any prospectus supplement. You therefore should carefully review any free writing prospectus in connection with your review of this prospectus and the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in this prospectus or any prospectus supplement, including any information that we
incorporate by reference, or any free writing prospectus that we distribute. We have not authorized anyone to provide you with different information, and we do not take any responsibility for, or provide any assurance as to the reliability of, any
other information that others may give you. You should not assume that the information contained or incorporated by reference in this prospectus or a prospectus supplement or contained in any free writing prospectus is accurate as of any date other
than the date of the document. We are not making an offer of securities in any jurisdiction where the offer is not permitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Throughout
this prospectus, when we use the terms &#147;we,&#148; &#147;us,&#148; &#147;our&#148; and similar terms, we are referring to Wingstop Inc. and its subsidiaries, collectively, as the context requires. The terms &#147;selling stockholder&#148; refers
to RC II WS LLC, a Georgia limited liability company, or RC II WS. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_4"></A>WHERE YOU CAN FIND MORE INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration statement that we have filed with the SEC registers the securities offered by this prospectus under the Securities
Act. The registration statement, including the exhibits to it, contains additional relevant information about us. The rules and regulations of the SEC allow us to omit some information included in the registration statement from this prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we file annual, quarterly and current reports, proxy and information statements and other information with the SEC. Our SEC
filings, including the registration statement, are available to the public from the SEC&#146;s website at http://www.sec.gov. To receive copies of public records not posted to the SEC&#146;s website at prescribed rates, you may complete an online
form at http://www.sec.gov, send a fax to (202)&nbsp;772-9337 or submit a written request to the SEC, Office of FOIA/PA Operations, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also make available free of charge on our website, www.wingstop.com, under &#147;Investor Relations/Financials/SEC Filings,&#148; all
materials that we file electronically with the SEC, including our annual reports on </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Form&nbsp;10-K, quarterly reports on Form&nbsp;10-Q, current reports on Form&nbsp;8-K, Section&nbsp;16 reports and amendments to those reports as soon as reasonably practicable after such
materials are electronically filed with, or furnished to, the SEC. Information contained on our website or any other website is not incorporated by reference into this prospectus and does not constitute a part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information we have filed with the SEC. This means that we can disclose
important information to you without actually including the specific information in this prospectus by referring you to other documents filed separately with the SEC. These other documents contain important information about us, our financial
condition and our results of operations. The information incorporated by reference is considered part of this prospectus from the date we file that document. Information that we file later with the SEC and that is incorporated by reference in this
prospectus will automatically update and may supersede information contained or incorporated by reference in this prospectus or any prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incorporate by reference in this prospectus the documents and portions of documents listed below and any future filings made with the SEC
under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act (other than, in each case, information deemed to have been furnished and not filed in accordance with SEC rules): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our annual report on Form 10-K for the year ended December&nbsp;26, 2015, filed on March&nbsp;4, 2016 (including information specifically incorporated by reference into our Form 10-K from our definitive proxy statement
relating to our 2016 annual meeting of stockholders, filed on March&nbsp;22, 2016); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our quarterly report on Form&nbsp;10-Q for the thirteen weeks ended March&nbsp;26, 2016, filed on May&nbsp;6, 2016; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our current reports on Form&nbsp;8-K filed on May&nbsp;5, 2016 (Item&nbsp;5.07 only), May&nbsp;20, 2016, June 30, 2016 and July&nbsp;6, 2016. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may obtain any of the documents incorporated by reference in this prospectus from the SEC through the SEC&#146;s website at the address
provided above. You may also request and we will provide, free of charge, a copy of any document incorporated by reference in this prospectus (excluding exhibits to such document unless an exhibit is specifically incorporated by reference in the
document) by visiting our internet website at www.wingstop.com or by writing or calling us at the following address and telephone number: Wingstop Inc., Corporate Secretary, 5501 LBJ Freeway, 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>
Floor, Dallas, Texas 75240, telephone (972)&nbsp;686-6500. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_6"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary does not contain all of the information that you should consider before making your investment decision. You should
read carefully the entire prospectus and the financial statements, notes to financial statements and other information incorporated by reference in this prospectus before making any investment decision. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Overview </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wingstop is a
high-growth franchisor and operator of restaurants that offer cooked-to-order, hand-sauced and tossed chicken wings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe we
pioneered the concept of wings as a &#147;center-of-the-plate&#148; item for all of our meal occasions. While other concepts include wings as add-on menu items or focus on wings in a bar or sports-centric setting, we are singularly focused on wings,
fries and sides, which generate approximately 90% of our system-wide sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We offer 11 bold, distinctive and craveable flavors on our
bone-in and boneless chicken wings paired with hand-cut, seasoned fries and sides made fresh daily. Our menu is highly-customizable for different dining occasions, and we believe it delivers a compelling value proposition for groups, families, and
individuals. We have broad and growing consumer appeal anchored by a sought after core demographic of 18-34 year old Millennials, which we believe is a loyal consumer group that dines at fast casual restaurants more frequently. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Founded in 1994 in Garland, Texas, we have sold approximately 4&nbsp;billion wings since our inception. Today, Wingstop is the largest fast
casual chicken wings-focused restaurant chain in the world and has demonstrated strong, consistent growth. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate and Other
Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first Wingstop restaurant opened in July 1994. Our operating company, Wingstop Restaurants Inc., was incorporated in
November 1996 and began offering franchises for Wingstop restaurants in May 1997. The first franchised restaurant opened in April 1998. On April&nbsp;9, 2010, Wingstop Holdings, Inc., the holding company for Wingstop Restaurants Inc., was acquired
by Wing Stop Holding Corporation. Wingstop Inc. was incorporated in Delaware on March&nbsp;18, 2015, as a wholly owned subsidiary of Wing Stop Holding Corporation. On May&nbsp;28, 2015, Wing Stop Holding Corporation merged with and into Wingstop
Inc., with Wingstop Inc. as the surviving corporation in the merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 5501 LBJ Freeway, 5th
Floor, Dallas, Texas 75240, and our telephone number at that address is (972)&nbsp;686-6500. Our website is located at www.wingstop.com. Our website, and the information on our website, is neither part of this prospectus nor incorporated by
reference herein. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_8"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An investment in our common stock involves a high degree of risk. Before making an investment decision, you should carefully consider the
specific risks described under the heading &#147;Risk Factors&#148; in the applicable prospectus supplement and under the caption &#147;Risk Factors&#148; in any of our filings with the SEC pursuant to Sections 13(a), 14 or 15(d) of the Exchange
Act, including, without limitation, our Annual Report on Form 10-K for the year ended December&nbsp;26, 2015, filed with the SEC on March&nbsp;4, 2016, which is on file with the SEC and incorporated by reference into this prospectus. If any of these
risks, as well as other risks and uncertainties that are not yet identified or that we currently think are immaterial, actually occur, our business, results of operations or financial condition could be materially and adversely affected. In such an
event, the trading price of our common stock could decline and you could lose part or all of your investment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_10"></A>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and the documents incorporated by reference in this prospectus contain statements about future events and expectations that
constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of our future financial and operating performance and growth plans, taking into account the information currently available to
us. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any
forward-looking statements and you should not place undue reliance on such statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Words such as &#147;anticipates,&#148;
&#147;believes,&#148; &#147;continues,&#148; &#147;estimates,&#148; &#147;expects,&#148; &#147;goal,&#148; &#147;objectives,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;opportunity,&#148; &#147;plans,&#148; &#147;potential,&#148;
&#147;near-term,&#148; &#147;long-term,&#148; &#147;projections,&#148; &#147;assumptions,&#148; &#147;projects,&#148; &#147;guidance,&#148; &#147;forecasts,&#148; &#147;outlook,&#148; &#147;target,&#148; &#147;trends,&#148; &#147;should,&#148;
&#147;could,&#148; &#147;would,&#148; &#147;will&#148; and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements included or incorporated by reference in this prospectus entirely by
our risk factors and other cautionary factors included or incorporated by reference into this prospectus which could cause our actual results to differ materially from those projected in any forward-looking statements we make. We assume no
obligation to update or revise these forward-looking statements included or incorporated by reference in this prospectus for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking
statements, even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_12"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder will receive all of the proceeds offered by this prospectus. We will not receive any proceeds from the sale of shares
by the selling stockholder. The selling stockholder will pay any customary underwriting discounts and commissions and similar selling expenses, if any, incurred by such selling stockholder in disposing of these shares. We will bear all other costs,
fees and expenses incurred in effecting the registration of the shares of common stock covered by this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_14"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description summarizes important terms of our capital stock. For a complete description, you should refer to our amended and
restated certificate of incorporation and amended and restated bylaws, copies of which are available upon request from us, as well as the relevant portions of the Delaware General Corporation Law. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>General</I>. Our amended
and restated certificate of incorporation authorizes the issuance of 100,000,000 shares of our common stock. As of June&nbsp;25, 2016, there were 28,685,268 shares of our common stock outstanding, par value $0.01 per share, and 19 stockholders of
record. The number of holders of record is based upon the actual number of holders registered at such date and does not include holders of shares in &#147;street name&#148; or persons, partnerships, associates, corporations or entities in security
position listings maintained by depositories. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting rights</I>. Except as required by law or matters relating solely to the terms of
preferred stock, the holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the election of directors, and do not have cumulative voting rights. Unless
otherwise required by law, matters submitted to a vote of our stockholders require the approval of a majority of votes cast by stockholders represented in person or by proxy and entitled to vote on such matter, except that directors are elected by a
plurality of votes cast. Accordingly, the holders of a majority of the shares of common stock entitled to vote in any election of directors are able to elect all of the directors standing for election, if they so choose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dividend rights</I>. Holders of common stock are entitled to receive ratably dividends if, as and when dividends are declared from time to
time by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any then outstanding preferred stock. Our ability to pay dividends is limited by covenants in our credit facilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other matters</I>. Upon our liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the
net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to any other distribution rights granted to holders of any outstanding preferred stock. Holders of common stock have
no preemptive or conversion rights or other subscription rights, and no redemption or sinking fund provisions are applicable to our common stock. All outstanding shares of common stock are fully paid and nonassessable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated
certificate of incorporation permits our board of directors, without further action of stockholders, to issue up to 15,000,000 shares of preferred stock from time to time in one or more classes or series. Our board of directors also may fix the
relative rights and preferences of those shares, including dividend rights, conversion rights, voting rights, redemption rights, terms of sinking funds, liquidation preferences and the number of shares constituting any class or series or the
designation of the class or series. Terms selected by our board of directors in the future could decrease the amount of earnings and assets available for distribution to holders of common stock or adversely affect the rights and powers, including
voting rights, of the holders of common stock without any further vote or action by the stockholders. As a result, the rights of holders of our common stock will be subject to, and may be adversely affected by, the rights of the holders of any
preferred stock that may be issued by us in the future, which could have the effect of decreasing the market price of our common stock. Currently, there are no shares of preferred stock outstanding, and we have no present intention to issue any
shares of preferred stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We entered into a registration rights agreement with RC&nbsp;II WS in connection with our initial public offering. The terms of the
registration rights agreement include provisions for demand registration rights in favor of RC&nbsp;II WS. Subject to the terms of the registration rights agreement, RC&nbsp;II WS, which is currently the holder of 12,765,858 shares of our common
stock, has the right to require that we register its remaining shares under the Securities Act for sale to the public. So long as we do not have an effective shelf registration statement with respect to our common stock, RC&nbsp;II WS may request
registration (a &#147;demand registration&#148;) of all or a portion of its common stock (&#147;registrable securities&#148;). We shall not be obligated to effectuate more than three demand registrations in any 12-month period. Any demand
registration must be for an anticipated aggregate offering price of at least $10&nbsp;million. The registration rights agreement provides that subject to certain limitations, at any time that we are eligible to use Form&nbsp;S-3, we will upon
request of RC&nbsp;II WS file a shelf registration statement covering all registrable securities and, if such shelf registration statement is not automatically effective, use reasonable best efforts to cause the shelf registration statement to be
declared effective. Once the shelf registration statement is effective, we are required to use reasonable best efforts to keep the shelf registration statement continuously effective and usable for resale of registrable securities. In addition, if
at any time we propose or are required to register any shares of our common stock under the Securities Act (other than a demand registration or pursuant to an employee benefit) (a &#147;piggyback registration&#148;), we are required to notify
RC&nbsp;II WS of its right to participate in such registration. We will use commercially reasonable efforts to cause registrable securities requested to be included in the registration to be so included. These piggyback registration rights are
subject to certain exceptions set forth in the registration rights agreement. The registration rights agreement also provides that, subject to limitations described below, RC&nbsp;II WS may effect an underwritten offering of registrable securities
after delivery of advance notice to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with an underwritten offering, we may have to agree to not effect any public sale
or distribution of equity securities (1)&nbsp;during the 90-day period following the effective date of any underwritten demand registration or (2)&nbsp;during the period ending 90&nbsp;days after commencement of such underwritten shelf offering,
unless the managing underwriters agree to a shorter period. Under the registration rights agreement, we have agreed, subject to certain limitations, to indemnify RC&nbsp;II WS and its respective officers, directors, managers and partners, and each
person controlling such holder against all losses, claims, actions, damages, liabilities and expenses in certain circumstances and to pay any expenses reasonably incurred in connection investigating, preparing or defending these, except insofar as
the same are caused by or contained in any information furnished in writing to us by such holder expressly for use therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must pay
all expenses, except for underwriters&#146; discounts and commissions, incurred in connection with the exercise of these demand and piggyback registration rights. The registration rights agreement does not provide for the payment of any
consideration by us to holders of registrable shares if a registration statement for the resale of shares of common stock held by holders of registrable shares is not declared effective or if the effectiveness is not maintained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the effectiveness of the registration statement of which this prospectus forms a part, all of the shares of our common stock entitled to
these registration rights will have been registered under the Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-takeover Effects of Provisions of our Certificate of Incorporation
and Bylaws and Delaware Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of the General Corporation Law of the State of Delaware, or DGCL, and our amended and
restated certificate of incorporation and amended and restated bylaws could have the effect of discouraging others from attempting an unsolicited offer to acquire our company. Such provisions may also have the effect of preventing changes in our
management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Election and removal of directors</I>. Our board of directors is divided into three classes, Class I, Class II and Class III. The initial
terms of Class I directors expired on May&nbsp;4, 2016 at the first annual meeting of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders. The initial terms of Class II directors will expire at the second annual meeting of our stockholders following the filing of our amended and restated certificate of incorporation.
The initial terms of Class III directors will expire at the third annual meeting of our stockholders following the filing of our amended and restated certificate of incorporation. Following their initial terms, each class of directors will be
elected for a three-year term. Our directors may be removed only by the affirmative vote of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of our then outstanding common stock and only for
cause. For more information on the terms of our directors, see the section entitled &#147;Management&#151;Board of Directors.&#148; This system of electing and removing directors generally makes it more difficult for stockholders to replace a
majority of our directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Authorized but unissued shares.&nbsp;</I>The authorized but unissued shares of our common stock and our
preferred stock are available for future issuance without any further vote or action by our stockholders. These additional shares may be utilized for a variety of corporate purposes, including future public offerings to raise additional capital,
corporate acquisitions and employee benefit plans. The existence of authorized but unissued shares of our common stock and our preferred stock could render more difficult or discourage an attempt to obtain control over us by means of a proxy
contest, tender offer, merger or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stockholder action; advance notification of stockholder nominations and
proposals.&nbsp;</I>Our amended and restated certificate of incorporation and amended and restated bylaws require that any action required or permitted to be taken by our stockholders must be effected at a duly called annual or special meeting of
stockholders and may not be effected by a consent in writing. Our amended and restated certificate of incorporation also requires that special meetings of stockholders be called only by a majority of our board of directors. In addition, our amended
and restated bylaws provide that candidates for director may be nominated and other business brought before an annual meeting only by the board of directors or by a stockholder who gives written notice to us no later than 90 days prior to nor
earlier than 120 days prior to the first anniversary of the last annual meeting of stockholders. These provisions may have the effect of deterring unsolicited offers to acquire our company or delaying changes in control of our management, which
could depress the market price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stockholder action by written consent.&nbsp;</I>The DGCL provides that, unless
otherwise stated in a corporation&#146;s certificate of incorporation, the stockholders may act by written consent without a meeting. Our amended and restated certificate of incorporation provides that any action required or permitted to be taken by
our stockholders at an annual meeting or special meeting of the stockholders may only be taken at an annual or special meeting before which it is properly brought, and not by written consent without a meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Special meeting of stockholders and advance notice requirements for stockholder proposals</I>. Our amended and restated certificate of
incorporation and amended and restated bylaws provide that, except as otherwise required by law, special meetings of the stockholders can only be called upon the request of a majority of our board of directors or, at the request of RC II WS so long
as RC II WS (or its affiliates) owns at least 10% of the voting power of all outstanding shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our
amended and restated bylaws require advance notice procedures for stockholder proposals to be brought before an annual meeting of the stockholders, including the nomination of directors. Stockholders at an annual meeting may only consider the
proposals specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors, or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has
delivered a timely written notice in proper form to our secretary, of the stockholder&#146;s intention to bring such business before the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions could have the effect of delaying until the next stockholder meeting any stockholder actions, even if they are favored by the
holders of a majority of our outstanding voting securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment to certificate of incorporation and bylaws</I>. The DGCL
provides generally that the affirmative vote of a majority of the outstanding stock entitled to vote on amendments to a corporation&#146;s certificate of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
incorporation or bylaws is required to approve such amendment, unless a corporation&#146;s certificate of incorporation or bylaws, as the case may be, requires a greater percentage. Our amended
and restated bylaws may be amended or repealed by a majority vote of our board of directors or, in addition to any other vote otherwise required by law, the approval by holders of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB
STYLE="vertical-align:bottom">3</SUB>% of the voting power of all of the then outstanding shares of the capital stock entitled to vote generally in the election of directors, voting together as a single class. Additionally, the approval by holders
of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the voting power of all of the then outstanding shares of the capital stock entitled to vote generally in the election of directors,
voting together as a single class, is required to amend or repeal or to adopt any provision inconsistent with the &#147;Classified Board of Directors,&#148; &#147;Action by Written Consent,&#148; &#147;Special Meetings of Stockholders,&#148;
&#147;Amendments to Certificate of Incorporation and Bylaws&#148; and &#147;Business Combinations&#148; provisions described in our amended and restated certificate of incorporation. These provisions may have the effect of deferring, delaying or
discouraging the removal of any anti-takeover defenses provided for in our amended and restated certificate of incorporation and our amended and restated bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>No cumulative voting</I>. The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors
unless our certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation expressly prohibits cumulative voting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate opportunity</I>. Our amended and restated certificate of incorporation provides that we renounce any interest or expectancy in,
or in being offered an opportunity to participate in, any business opportunity that may from time to time be presented to Roark or any of its officers, directors, agents, stockholders, members, partners, affiliates and subsidiaries (other than us
and our subsidiaries) and that may be a business opportunity for Roark, even if the opportunity is one that we might reasonably have pursued or had the ability or desire to pursue if granted the opportunity to do so. No such person will be liable to
us for breach of any fiduciary or other duty, as a director or officer or otherwise, by reason of the fact that such person, acting in good faith, pursues or acquires any such business opportunity, directs any such business opportunity to another
person or fails to present any such business opportunity, or information regarding any such business opportunity, to us unless, in the case of any such person who is our director or officer, any such business opportunity is expressly offered to such
director or officer solely in his or her capacity as our director or officer. None of Roark, any of the investment funds associated with Roark or any of their respective representatives has any duty to refrain from engaging directly or indirectly in
the same or similar business activities or lines of business as us or any of our subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Exclusive jurisdiction of certain
actions. </I>Our amended and restated certificate of incorporation requires, to the fullest extent permitted by law that derivative actions brought in the name of the company, actions against directors, officers and employees for breach of fiduciary
duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware. Although we believe this provision benefits the company by providing increased consistency in the application of Delaware law in the types of
lawsuits to which it applies, the provision may have the effect of discouraging lawsuits against our directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Business
combinations</I>. We have opted out of Section&nbsp;203 of the DGCL. However, our amended and restated certificate of incorporation contains similar provisions providing that we may not engage in certain &#147;business combinations&#148; with any
&#147;interested stockholder&#148; for a three-year period following the time that the stockholder became an interested stockholder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction
commenced, excluding certain shares; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at or subsequent to that time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB
STYLE="vertical-align:bottom">3</SUB>% of the outstanding voting stock that is not owned by the interested stockholder. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, a &#147;business combination&#148; includes a merger, asset or stock sale or other
transaction resulting in a financial benefit to the interested stockholder. Subject to certain exceptions, an &#147;interested stockholder&#148; is a person who, together with that person&#146;s affiliates and associates, owns, or within the
previous three years owned, 15% or more of our voting stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under certain circumstances, this provision will make it more difficult for
a person who would be an &#147;interested stockholder&#148; to effect various business combinations with a corporation for a three-year period. This provision may encourage companies interested in acquiring our company to negotiate in advance with
our board of directors because the stockholder approval requirement would be avoided if our board of directors approves either the business combination or the transaction which results in the stockholder becoming an interested stockholder. These
provisions also may have the effect of preventing changes in our board of directors and may make it more difficult to accomplish transactions which stockholders may otherwise deem to be in their best interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides that RC&nbsp;II WS, any affiliated investment entity, and any of their
respective direct or indirect transferees of at least 15% of our outstanding common stock and any group as to which such persons are party to, do not constitute &#147;interested stockholders&#148; for purposes of this provision. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation of Liability and Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws limit the liability of our directors to the fullest extent permitted by applicable law and provides that we
will indemnify them to the fullest extent permitted by such law. We have entered into indemnification agreements with our current directors and executive officers and expect to enter into a similar agreement with any new directors or executive
officers. We also maintain directors&#146; and officers&#146; liability insurance coverage. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is listed on Nasdaq under the symbol &#147;WING.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
transfer agent and registrar for our common stock is Computershare Trust Company, N.A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_16"></A>SELLING STOCKHOLDER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the name of the selling stockholder, the number of shares of our common stock and the percentage of shares of
our common stock beneficially owned by the selling stockholder prior to this offering, the number of shares that may be offered under this prospectus by the selling stockholder, and the number of shares of our common stock and the percentage of our
common stock to be beneficially owned by the selling stockholder after completion of this offering, assuming that all shares offered hereunder are sold as contemplated herein. The number of shares in the column &#147;Maximum Number of Shares That
May Be Offered&#148; represents all of the shares that the selling stockholder may offer under this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership for
the purposes of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the
voting thereof, or to dispose or direct the disposition thereof or has the right to acquire such powers within 60 days. Percentage of beneficial ownership is based on 28,685,268 shares of common stock outstanding as of June&nbsp;25, 2016. Except as
disclosed in the footnotes to this table, we believe that the selling stockholder identified in the table possesses sole voting and investment power over all shares of common stock shown as beneficially owned by the selling stockholder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially Owned<BR>Prior to This Offering (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>Number of<BR>Shares That<BR>May Be<BR>Offered</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially<BR>Owned<BR>After This Offering</B><br><B>(assuming the sale of<BR>all shares that may be<BR>sold hereunder)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Principal and Selling Stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RC II WS LLC (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,765,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,765,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">RC II WS LLC directly owns 12,765,858 shares of common stock. RC II WS LLC, a Georgia limited liability company, is controlled by Roark Capital Partners II, LP, a Delaware limited partnership. Roark Capital Partners II,
LP is controlled by its general partner, Roark Capital GenPar II, LLC, a Delaware limited liability company, which is in turn controlled by its managing member, Neal K. Aronson, who has served as the chairman of our board of directors since February
2015 and is a member of our compensation committee. Each of Roark Capital Partners II, LP, Roark Capital GenPar II, LLC and Mr.&nbsp;Aronson may be deemed to have voting and dispositive power with respect to the common stock directly owned by RC II
WS LLC and therefore be deemed to be the beneficial owner of the common stock held by RC II WS LLC, but each disclaim beneficial ownership of such common stock. The principal business address of each of the entities and persons identified in this
paragraph is c/o Roark Capital Management, LLC, 1180 Peachtree Street, Suite 2500, Atlanta, GA, 30309. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_18"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may offer and sell, from time to time, some or all of the shares of common stock covered by this prospectus.
Registration of the shares of common stock covered by this prospectus does not mean, however, that those shares necessarily will be offered or sold. We will not receive any proceeds from any sale by the selling stockholder of the securities. See
&#147;Use of Proceeds.&#148; We will pay all costs, expenses and fees in connection with the registration of the shares of common stock, including fees of our counsel and accountants, fees payable to the SEC and fees of counsel to the selling
stockholder. The selling stockholder will pay all underwriting discounts and commissions and similar selling expenses, if any, attributable to the sale of the shares of common stock covered by this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may sell the shares of common stock covered by this prospectus from time to time, at market prices prevailing at the
time of sale, at prices related to market prices, at a fixed price or prices subject to change or at negotiated prices, by a variety of methods including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in privately negotiated transactions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through broker-dealers, who may act as agents or principals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in a block trade in which a broker-dealer will attempt to sell a block of shares of common stock as agent but may position and resell a portion of the block as principal to facilitate the transaction; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through one or more underwriters on a firm commitment or best-efforts basis; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">directly to one or more purchasers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">through agents; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in any combination of the above. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In effecting sales, brokers or dealers engaged by the
selling stockholder may arrange for other brokers or dealers to participate. Broker-dealer transactions may include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">purchases of the shares of common stock by a broker-dealer as principal and resales of the shares of common stock by the broker-dealer for its account pursuant to this prospectus; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ordinary brokerage transactions; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">transactions in which the broker-dealer solicits purchasers. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At any time a particular offer
of the shares of common stock covered by this prospectus is made, a revised prospectus or prospectus supplement, if required, will be distributed which will set forth the aggregate amount of shares of common stock covered by this prospectus being
offered and the terms of the offering, including the name or names of any underwriters, dealers, brokers or agents, any discounts, commissions, concessions and other items constituting compensation from the selling stockholder and any discounts,
commissions or concessions allowed or reallowed or paid to dealers. Such prospectus supplement, and, if necessary, a post-effective amendment to the registration statement of which this prospectus is a part, will be filed with the SEC to reflect the
disclosure of additional information with respect to the distribution of the shares of common stock covered by this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with the sale of the shares of common stock covered by this prospectus through underwriters, underwriters may receive compensation in the form of underwriting discounts or commissions and may also receive commissions from purchasers of
shares of common stock for whom they may act as agent. Underwriters may sell to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the
purchasers for whom they may act as agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any underwriters, broker-dealers or agents participating in the distribution of the shares of
common stock covered by this prospectus may be deemed to be &#147;underwriters&#148; within the meaning of the Securities Act, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any commissions received by any of those underwriters, broker-dealers or agents may be deemed to be underwriting commissions under the Securities Act. The selling stockholder may also be deemed
to be an underwriter, and any discounts and commissions it receives and any profit it realizes on the sale of the common stock may be deemed to be underwriting commissions under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholder may enter into derivative transactions with third parties, or sell shares of common stock not covered by this
prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell shares of common stock covered by this prospectus and the
applicable prospectus supplement, including in short sale transactions. If so, the third party may use shares of common stock pledged by the selling stockholder or borrowed from the selling stockholder or others to settle those sales or to close out
any related open borrowings of stock, and may use shares of common stock received from the selling stockholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an
underwriter and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective amendment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may authorize underwriters, dealers and agents to solicit from third parties offers to purchase shares of common stock under contracts
providing for payment and delivery on future dates. The applicable prospectus supplement will describe the material terms of these contracts, including any conditions to the purchasers&#146; obligations, and will include any required information
about commissions we may pay for soliciting these contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers, agents and other persons may be entitled, under
agreements that they may enter into with us and the selling stockholder, to indemnification by us and the selling stockholder against certain liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may
include short sales, stabilizing transactions and purchases to cover positions created by short sales. Shorts sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering.
&#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares from the Company in the offering. The underwriters may close out any covered short position by either exercising
their option to purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for
purchase in the open market as compared to the price at which they may purchase shares through the overallotment option. &#147;Naked&#148; short sales are any sales in excess of such option. The underwriters must close out any naked short position
by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market after pricing that could adversely
affect investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of common stock made by the underwriters in the open market prior to the completion of the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the
underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases to cover a short position and stabilizing transactions may have the effect of preventing or retarding a decline in the market price
of the Company&#146;s stock, and together with the imposition of the penalty bid, may stabilize, maintain or otherwise affect the market price of the common stock. As a result, the price of the common stock may be higher than the price that
otherwise might exist in the open market. If these activities are commenced, they may be discontinued at any time. These transactions may be effected on The Nasdaq Global Select Market, in the over-the-counter market or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain underwriters, agents or dealers or their affiliates may have provided from time to time,
and may provide in the future, investment, commercial banking, derivatives and financial advisory services to the Company, the selling stockholder and their respective affiliates in the ordinary course of business, for which they have received or
may receive customary fees and commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the shares of common stock covered by this prospectus may be sold in private
transactions or under Rule 144 under the Securities Act rather than pursuant to this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_20"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the common stock offered hereby is being passed upon for us by our counsel, King&nbsp;&amp; Spalding LLP. Any underwriters
will be represented by their own legal counsel. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc237680_22"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Wingstop Inc. and subsidiaries at December&nbsp;26, 2015 and December&nbsp;27, 2014 and for each of
the three fiscal years in the period ended December&nbsp;26, 2015 incorporated by reference in this Prospectus and Registration Statement have been audited by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in
their report thereon incorporated by reference herein, and are incorporated by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>6,000,000 Shares </B></P>
<P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g237680g43q65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:80pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:245pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g237680g43q65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g237680g43q65.jpg
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M %?3EX[O],?T_D/?Z^WZ?N_M^N/1ZK,?O#?[ Z/P[^Z''OM.R?XKS_V/HQY
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M!&JV&C$=L^VSITWE%QBSCA)/WQE1 4')O\X_Y+-3.,X]+)9S$A[58UY^;HR
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M] \V1P;-FK,<FDFOL0MJA9.ST1;939ND7I<BD/A\9'(*:IC/QQ133=5XT]J
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M$.&T(+II:O'BOW-FQ4*/W&R>N'1DBCL3(_+T6>;Y5S[:V6...)0D:*BC\U0
M.?F?M/U)[GYZ^R\3A\9@Z4=#$8ZGBZB?%Z6C"D,(D8#K<]"(99&X'5-(/-DX
M!<\ZDWUWJ3T>C1H]&C1Z-&CT:-'HT:/1HU3MTGY,P@NUW_-W!M1M^O\ L/?5
MPQ+_ ,,IMM*IJ+.JN&;LC;-E-U6C/5,4[V31(@V1P>U0=Z*!SDHCAG#8>ZCI
M[H$AAJQ>IL>QX_:X_E^,?M['W ('R+*>QQ_<GB7!%E7VWL3$KN_>!ZHY?3!1
MBL1P>AY,KDE*)Q$Y EA2>-%<&&>U6FZ8WKMZ$J>J^=I73'0'FNM&R^L;'LB;
M#0T3KB(1*3H<<T(R=OVGXZ]>-V+ 8$D6L8$_,).02;?4_,FK);5] 98FFXE"
M3.:..%HYLF[V'=P%15/IX@>.>>P!Z1W('=N.Z-W;6>;@Q6+V[:PV?\:<GDMU
MY')7HX:F.IU+2[/P*.Z>>[K''%#9]+%S(T 7U%U(R'H6P&M#/O+5*.@Q-D^-
M!3Q_7$WC<'LPG(6=60:$&P :AI1,H;I%)15B.[(*T1CAX=-6IMY'18T\Z=PY
M#+(>HB@"PH3*J=9!I@]+T<G2KEA&J,HB9EZ6C[#X2&!*CGE.P]NYT_\ %BUN
M"+)>&IV!F%K4<G)83%TJ,T$."M7*8J6L6#' @KSQW4G>O%'.STEZ(R%K\R2F
M!9-W-&^J.[_$=8Y:.NJLZ"K2X[<H#I.ES:3E@=KV<GV<.C@O=LT(XT(JQ:3/
M3$G_  19UKETR<,2((CNH0'++N$FM+/:Q[E?+F222&:(]BC'H4>_?@EFXY]B
M"#W!.H&SOBONG?7A+D9J[8O/XW,9; ;DPTX9)\?>G6G6B*I(!(:MF2:UY#,"
MT;1R02$R1EFS)W5L=IGRL]R<039PSCM(>4ZBY#*8.Y(;)M1C2TY -D9)F1;;
MK9U9(D!\WVMUN#9M_A=+%%HBW;I[+JLVZO118K]JJ_PQ7XBRD\<>80Q!Y^7#
M^:%'UZ??MIX^+KX;Q4WQLBZR5\)XHX.Q:HM(0L2Y2Q%9ECD4L>A9([WWW6!5
M/496J*HZF12UOC(HV-=1>,@'S/W%1!1VVI:43F!C'%E1,_&]W,80*O3,8GM7
MSMVS&;8;"61A[$F<G@YK^2SC?R'JV1[]/#]>C$L]$0VHB1$SJ"ZLOP\E@Z/V
M]N2O*GV7O[][7X9X.MNCPSAVUO?!2NN%M7J,39*K8K%JRS//6OXN^R1$+"DS
MTTM49^R5NEV\N0!T3HNB>(?&-V#<$^F_D Y\GO-\YJN34R7I61$GER7 0@LB
M81Q?>,SF/UV(-#,:@R\::!&FB@55,M$-=V^PL6L[W:HMH8JM*Q([6X7A:-HC
M&3YLA5@I*N$!'8KQ[=U[<#GC5&P6"V3X9[OR]^[O[;]_;E[%V<-+A;$CYG+R
M4;*5V-:]7QT,T7XB:LD*<P$2U.5,41;I$1(33QQ RT@'\.W!YI1L"D!5X]>5
M;Q2Z/CZZR\=;^RWX0UG;0;(FGS-<81W7++&26$<:I?%C77Y?I/JI L*TF2"L
M3^+K$A/U=8#?R\GCMJ'6[X<P2V(]D9CQFCH3RN[8O9CSQX[K8]_*6\D=A>?8
MM,9I>.W/';35<HVQ"^4I ?L&B?#_ .3B>6?,6*@N2WC>T:D):SI()77:NE6:
MYHPR>BF#5VX8LUWVL?8#=2*C5ID@J[PT:817KR)78O#CKSNW9I95;K8<@GDD
M%1[=^..2!SJU;4RM+:MBQD,%X1>)E[)W(S%9S>=K6)<G9B9D<HT\T;Q1J[(C
M2>GCC\PHGF%PJ=+Z=;]=2.5P /45I>+#L&^:ON.GJZF\_!P2/'22<=*29NVD
M;^L))_#C8:71ET!,,FB!E-J09*)$FZ*FJ:&VF-<.K%@L@CDH6)4DC1W"!B 3
MPQ0E>#U(1W'(//'MJ^;MW;9M4(<1E/"W=^>Q>8P^.O7X*%>Q**\ME5LR8NSZ
M98Y5MT)D19@LB$2J" I &J36I#E&H4'0@2Y\_/ 4-7665>0\7L0"5:(16VVW
M6T:(;N%9+IKIC??XUR"9%?;3WVW44WVW^*,!KQ @??:HI/=1VC'/_6^OOR?]
M^L563:F(#0Q-X]["ILS%Z<1>#%PAB>H(I8VAQWY:02,1[DGG5H'C9Z+\+?.(
MV6CJ'ZD1TL*TRC,G9=A=.EY!%+$EQ-JJ_<,T3LIG,7@\-U2;O2Y1W\ +*23Q
M\1<.R;HB]^%?1_2FQL(813_&Y!=YR5=CWX!9U5>Q)_)^9[DG6G>&^XO!C;D5
MN/!;H7[X921)<ED-S2V*F0MRH9'03VKU6C2X5YI7X@X$DDC-(TLGQ!@?&9RU
M85>]!]X=66D:K.8/^H[.'G:UE-4SQE8L/1KE,Q,320(=($F8I_LNP2+1L6^T
M>AF:"R  2NQ5<?$ZT;JT8'2:W/(48SR HT;AUZ.7/2#P#VY4=P/R1]NK!X:;
M7R&/W!OO=64FQMQ]T9..?&V\5>CR-08X37)A!'85(I.J,35HI \**RUX60M\
M858^-;<KCA'R$>0RC^K3HBI9)TQ=[CH&EK;GKI !#;+@,C,2PJ,C6LV*[M@K
M-Y&?XCV8,&KQ\@R5.XE(-!1N38M6+Y&M(E2W;BL$1M-*9HY&^%'5BQ"]1[#I
MZNW)XYZAV/ -8V;EL=L7Q \0<)NJ>'$V=RYML_A<M?9:]/)4+,UN6*MZV4K"
MC5O4=$:.ZH9_50*5D1$DQ;S WQ274DTXNYIYHGT+M#I$7TW$K.1FE<GQ4G'T
MK 8R+++2X])IB!<O!@%JCG\(F)ACL1U4'A8(M(#"+--F%4><Y&:*=JT$#K),
M)E?K1@PB4 ]1+#D#Y,1SV"=1XX&FOB]G<)NB[LS;6VK]+*;CBW-4R8NXZ>&U
M'A:%:*5K<]FY SQP(.8;LR>9S'!1:Q,$"0ETWH*R.E?)!WQV%T!R7VA'>8Y-
M&EHX'HFKY$]0=#;QAD5P_""-I;72SERH1 I@@G\1R:0NX?-7,;-3%H/'L]$&
M^BS%M"\]VW8E@LB!AQY49/:55[#J3YKTCJ8]+\%N/MU3\!DMR^(V_-WY_:>\
MZVV;-9J\6"Q=F16CSE.KUP0^JQQ9C)7$$'J;5AZ=UZT]Q(XT"@-'*0FM0-U]
M4L*1ONN3'B]\J.P@A**IZ-YD(_=*:Z,29ID7;TF[C(XHD))[&T!!9V3':EDB
M4DW&E!A^2MR2&D&64""6QY4R&C?X+1S0'B.;CD\E0>#SP>1SRW!#,".C4I#C
MH,UNF/"9['3>&'BEY,EG%;BVS)T8;<802.\KU8I!%)YXBE>6/S?,L^5+'8LK
M(HHE\XWY!+]X]DX.C/+76@E.*&B* 6 ]MUJ"4-TE.76N<_<=;) M1NF8+(EL
M)*K.56HD7\O;&[K,,&QYHO*%70MRUV$60C'23PEE%ZHF/^> /@/Z /KT@?%J
M]5M_Y_:%F#!^+.-B%6>18:&]<; 9\+=?\P9*!8AZ&P0"S,L4?!Y;T<==&M&\
M",FHU)(\%/PXJ$.Q0R-:DX\:C3YB2 %1+Q+5=D_#D!BJP]Z/=(;Z+-G+-51N
MLEMKNEOMKG&?4HI4@%2"I'(*D$$'N"".Q!^HUMU:>M9KPV*<T%BK-&DM>>M(
MDM>6%P&22&2(M&\;*059"58$$$C7N>O=+Z/1HT>C1H]&C1Z-&CT:-'HT:/1H
MUKW.@'^$!W-F6@ OR. >]9J) RE 6-^-#G;HMVHZU +HZ-4=MFL"E2CTAEJP
M0^4V8"UR;=LV23@@9H=B./O=:Z@/[DML W _:9N_3_J-R>![ $@#X!U?/SP?
ML1;X]7!#T[ WY=B@M+%'\.W=Q.6$#*%'P4+1>3IC7A4B:15510A2>\JVZBK2
M]Z]DM56]#0L]K^7,-QYZ-'FWWAFZ2SG&Z#ENKILF[&E&"^J;P48&N&A4001;
MD!KQJ];HKZ2DD:2HT<BAD8<$'^D?0CW!'<'N-;AEL1C<[C[.*R]."_C[:&.>
MM.O4C#W5E(X>.6-N'BFC9)8I LD;HZAAI]]?<2=;^.^TN9P-.N9[T)QP [ K
M:YZ- ,!+V8655ME!R;PJ_K-,:)14?Y:S$8F^>97#L/P&6/0;=^Z8 3^229NN
MV*MBF\ BZYJXL))$ "SQN#R4X'R8<GL.EB.2 >>?D+=VRMV>'F4VU!AVO[@V
M?!N_&YG!UXXGN9+%Y*&1YI,8(X@9 MV,2.6A3T]N2!9'C@L>8)[2/*'27CYC
M-^\]=L77T CS);]9R"-SUV.A(-@;M^[M(6^&&*^;ZU\Z:%'B16/F1: U>9&8
M@48Z!\Z163YT8M13@&^O14UFBLRS>1(A#D( 9)>D@I\'!(*D<=14CCLW8 KJ
M'B?A?#^MG]O[US6X%VSE\98KY!XZ4$<^7S8I/%-CU&/=)7$M>:)8VN34Y8Q#
MQ5M<(L30?%[?7<G<<^$V=QSP; Z)'L@N(Y$>QNX@S1*=C8HX>.26%ZQKIJV)
M'0J+]=TL^U(BTIK'3^<-$S#A'#9AEN&6U:8/7J)%P.E+-H?&%/?X$X)'/OR.
MM3\]>/G=\;WOPY/9^Q*&"C2'T]3>&]X4%^*JSM)SC,>BRSP!V9G$D0NU['P"
M9EZ8^F";YY[Y3A>79;RW^6*PK_E#/.7A2@XC-DX+#4'7OA11@A0]6_Q)+L:_
M-QAJ@7%CX2FO\.%'2+75/&K9*6&!>^0R#RM[F)6Z5!^8\J/J;]8"<_0:@L[M
M_:M+KE\6?%?(9^TGQRX&I=%&FK<\^6,%B_4V_?X1-%'2#<<NJ <*@?5?1$'Y
M0A=5WAXY.4./\<J6NPV&0J_Y12Q&S[NA=F $]T);5]B'[,DTF4B<N9*-]CX9
MD_8*Z2*/KHD1KLHD.?.?32>9($CEIUZ_IW[+,T?F2I(/RHW,C,58>X!'#*>0
M3P3JA;JW#1VI3Q6;\.MJ;1_!7*QF*EG[6&DRF;I9*N"MO&9"QD[5IJEM"OJ(
M4DC(LUV62-Y5B=M9L5[S[?'I\61VO.VG-Q=DWM*HK(VU.16(5$,Y="02<I-1
ML0K:9/0,.B:+V0;/G.P\X4#2(DD#+-IA'B6D3,0P'+9'V;=H>F5+7FV)64^6
MJQB (W 5&Z47D\]B02 0P/25#,]EWWO>,;+KX_>K9C>&<M5;*X>K3Q$6V(*%
MT+'4QMQZ].H'L&1C'/+#9D$$JW*THJ34X+=F&[TZQCMRS24-;DZB\@_CFO,*
M:4%61 TIY:O0W-8Z6?)PY>LXP-%V1'[)K19[ONJ^WB&K67AX\VSH.$8P@SRG
MZ2EL+(S"6>W3E!X=>N2:$-\PH#B1#WYZ?B"CL-0^<W77S%VRF8W1X@>'>=AF
M,62H"_E-P;;CM]/4Z58HLE7R6,+DES4"7(:Z\1PCI0ZAH+:M15^ZT.R;S5=H
MV2/:;87WAO.D/Z,C4T-:Z?F^Z-I9<\^@\8CSC;&/_?5Q\A11S^;[NKC7ZIB2
M-/B.2LOQ^;"LRL?]:1U4?[_T:AH<IB<>PGL^,^\LE&IZC3V[3W%6NS =^A+>
M9OT:M=CP/C:.PH]^D\#EQU_(MV'+7/*HZ.6G8G#/&UB$K,#5G?5O3%ET;=%O
MR:"Q]TLJ7LB06$J6+N0IF8OHY%4M1L8"US$WTG44PY.LP#5)@X-RR?3\.]6L
MY<)-(WGRR% >[L_)(+<#LH12WYP4<7!O$3>%MMK)6RN0V/L[(29.'&Y[+W$W
M'F<O:H0,6FR5C(&69X9KCUZH\NK!C:CVB>JPE=1&LDX[>[>7Z+?<G])\T\A=
MKW%K+AL%T%3/GV$F9/("QM!DZ%K1295HE7[\:Y(C231]H36;M%Q""RVQQFP5
M:/T&Z+VK7G&":&O9DZ@G#PHQ)/MTLG0>X/8_+GN!WU6KV]M[MN)]J;DVWM'>
MN8%N*B(KNWZ,]FQ-.J/$:ES&KCWC:2.1'$K*C0JQ,Z1E)%5\V$ \38&V#%;U
MCV%/_'#UM$/P@//C%(6S/T^<EK-T&LU9E'ADPG2[T.>CD2D;A]&7K0G,8 T=
MO!SQ!LT58:+:>G06@LA1+#T["\!C%(_D]? Z@&;GD*>5/+)R>?<:O<=#PI@R
MLV-QF\+_ (<[LI^5#?FPF6R VX<F(D-RO'<O,\4]>I8:2LZ27<>CO$ZJAC!&
MFKM2M/(4.@8IM>U1<O\ FGY@;:[% 4C""X_".@A@O;75#8[%=QB+P&\?+-=-
M$_B@VTTE)SY?R7)I%/9PONX=+?0/-CKY.#W5@ LP'U4CX>?E\'4S?-O?5IRN
M,\08Z$29W$[8\9]L+^-@L0104MP11<=)GJF(- [E.!S1-VU/QTO,H+,8T R3
MB.[^=;NY=\=,:J?A+LFU8ZYK::UKTO%#]:7*]!%%&^)77P&<$G,@?/GDA'IO
M0S8*P('5D6C]0F_C4?<)HO$$PU66&2"F(ZMEUZ&2=2DA!(ZD#GDGJ'(X!8\'
MDJOOJ-@L[)S>W<WMCP\K8K8N\<K7;&W<;N6K/C,R\$I3U6/@O2/8=VL1AX5@
MCDG8)(99*M=@'#OQ_P ('(Q7EJCJO/Q0M7EYUE"PR^O0U9D6T2N$?93K.TBD
M)A\>#K$!LE;-9<_(X$#S2D@2 B4VPZ+F&&&[8CAT,97,$494I*B@^<A"R!S\
M3$L.0P#$\ \]([*1[ZN]?P2VE+M?"8RQ4EQ^<QM*%OPAQDBU,O'DF_NBQ-)/
M"9([*I;DD\F.8V!!"%CJS1]*R#H\Z>(RQX5UW"NL>I^RIKUI(*9CCB-TNRD\
M67 /A":K4NR9/Y,2<2V2Y);AT3QAZBU:I)KE)&[2D)4LKNTR/=>0X]TL+//9
M:P8UXCZE(([$<L2S<\<D_:>Y/RTGMWPER5+=U+=>Z=Y7=V6,-7:MADLU6@DB
M!65$DLRO;L^885GF<*H#2V7%B68E/+>4?+/TBA#ZF$<B5Q!H]<W3O8^SBLJJ
MJHZ)&204-$D=LMC]IRX.50=#&X"')85>"'IE' _0ZS_&7&%@D6DJC)3(3=,8
MKHBRSV?Q<<; $ 'WD8'MPON">W/?N%;B4\6-QK4Q,.T<=1KYG<V\2V,Q6*GB
MBLQ1Q2'IGREN&56B6"F 7A>8>6)T\]NJ"K9*-)P1R$ X<YAK_G\,;>R<@#2=
M')G)'3EZJV.3J0;)O),^"L7:FV@2/:O-<,P8AJDWU1'-4'1##HV[*D7J]2N*
ML"0@]1')9N_=V[L0#[#GL!].Y[DDVC8>T:^R-L8_ 0SO:D@#3W;+,Y6>]8(>
MR\*.2(*X?X((5"\1JKR=<[RR.Y/ISJXZ/1HT>C1H]&C1Z-&CT:-'HT:/1HUC
M4OC#*8QTG'WBRK+9ZWW_  XRS;C7!6.&4L94#R@!DLQ)L&LBCA'5N9 OW#!U
MJQ*LVCKY*GRO@SRRA@0?U$<<@_)AR".I3W!X/!&FUNJERO+7<E"ZGRYD6-I:
MTP[PVH/-22-;%:3IF@D9&\N5$?@\<:I%X[[9+<>2.XN'/([;3,1,^?A3V?U'
MT18I9=LSOOGY\_5R&)9*DUW3LY.@:BFHO4.U<E3Y7X'4;;(%#<.,/2$96M&N
MTE6[( T(ZXYG/[;$3V/)[EA[<=V/<=RI)Q/9^]9MH6<QLCQ&RR17<!$]_$;A
MR,Q5,]@'<F&0RRLSSWH"?+\E6EL2\/6599J<TDGC&^T^T/(7@R-X)CZ'+7*0
MW)!.6=YWX(3'$"X<?\Y(T^IF#E_@2^[H-D7VVDA(Y6RVUT^ L8K,TVQKMX;5
MFWR*@$%<<]5J8<$\>YC4]OUG]90C2,V\]Y^(/G1[#KKM?:D?F"WOO/1".2:&
M/D3/AJ,W Z0JOQ8DZNGCB6;&3IJN33I/QT<4SQ^GS!6]B>5GO$B\W=FK_FFY
M2PV>LLUSHFL5CT@V'23=RLU<[ZJ#W%;1XP]?#]\BG]K*JIZJX9>=3K/^)1\A
M;/<S-RXZOJI(;GCY= )([&3GOK.AN/P[V7?<;8QN1\5-]R.7FS]TRY!/5=@9
M:]@QV2[(2#&V-KS/)'^*DRW4.1@-G!?M#?D*RX2*0.QJ1K,O\>-X,-)AN:8L
MU'N<_5H9'R:3"K5E3/?7.GS64B<2;3&=,;Z,T<>^/7+C+W/=)(D/Y@(@4 _(
MAF61A_RNK3#)P_=!^(/4)*.1PF,FY!HQR0[:JI&WYDT=FS#E;<9''*6&LCL"
M$&HRC/V:'N@TQ5?22S>;8H\43V42&.Y?8)I_ESM^;.C]<36C@<AKG.<_$NT(
M$MOB]\_*VQ[9SP,+:(Y+PJ?H6<GG[2$(_6"=1M;[FS?$R&2SD]N5'()$3V\A
M-)U?21H<:T:CGW9))3]AUCLIY7[)\.L.*N^DX74?2/%%^2$?7-T55'YD;+1,
MZ4W8OBL>.#ES,9C$FKNQ1S4.1>0RPPPE3[@0&(,R:OSLA$_7+5[&.4^>L<U:
M5@DD:L2I/NI'*JR.."5<#L1P?EIM:VMO'P?IRON2EB=Q[+SUB/'9G%5[DTU2
M>7HDEKSQM-6K6<=D(TAD>ED883Y<D2I*>HP#6.4-1TMKVQT.MO#_ &%$NCFX
MEFH\.<[6<"B.O5M5A%731\7CQ&%D]VI*5#%4VV@)6R:&.LCIH8\* $=/PYT9
MP^YBB9'%C'NLW'<PN%]0@^8*]BP^1>%@2"1V!/+;!82WC\DN[/"'(5-Q+$A>
M;;V3@J#=6+A+*\U>6E(4EM1$*(#DL#.D\T;RUU_%M-UILGU)/^=>0;/X@+4D
M1B\ZN&?R>279)+>$2L=)VHK;6L/X+&QB(D'H5FQ-AW\(DJ[T_,H_(20_>3.=
MXHN#=KD'"S?SWAKO5,?2TCLTID#!N/Q?0%7D $%6Y+*Q'5\/!YU3QNB_MW:.
M3V3+A)*M[,7[-G-6<O%:CLI"1C/11U:<CPI'/#)1LE[%RO8DC-EC4:!VD8MQ
M'/)=2%,]I5AT-6<3D1BN0'&,;HZ2Q$''6E>&,V$!CF[_ $3RL-D++#\(5LZ/
MQ<A*) W(,G9*)%#K5004<:+C"[A;L45E)D0E!66)E "'K"_8>X,@4D]B5)'!
M]C;*WB5A,-O/%[AQE2S+CJ^S:V#LU(:Z8^;[X05BX',5A!)!+DZ]62S861'E
MIRSH896!BFA&!<Y===+U]:$)@-7?[/./CUY+W^/NKI9,95$(J/.69X X*-[)
M>XCD4W:G(R8"#Y^(@L>/ZEEXG$70H$*2%();))#8F2143HKF7SA+.!&D?9EY
MZ^R<$, X0'DJA  &H2AMS=NY<?DZ5#&?>_:$^<.?CS6Y!%B:.)/18KM*,D_I
MZI6>M-!'?BHU[ E:I3:*"(1*-3-61V*5W.6G)_C0*O\ HGMF_MR\+GW;D@35
MB[4$P?C7Y*<QWFUM(5?Q6+"/P5F7<3&[CRNDL*"V15S%D$&[X0X&JH51Q7I'
MSK,W*O:;X0 02XA![J. >J5OB(!Z?<<3.-FJ8^\FU/#663<6]<^9J=_>M@&J
ML"/%))>K;;6P?-JP^2DS7,W886Y8DE:JJK)"T6=QO[.'VY+!A<BSMOD[<B+>
MN!SX.A9LZ,OFIEKG79\)+.P=5DQHXHA\S7YC5=]NKJIOKAQA#3;"OKM<-:8$
M^97Y!XXZW/!'N#Q&0#]G/\FG];[G3>UN*61,MM0R1.T<D(R=Z:1)E[O%*\&*
MEBCE7GNK2$\GXND'G78A/CG\Y/ Q=>4<\LI;H/;N/O9!&F+0B$PBIU5+X<Z[
M&*GD1-#>59VTT]D\$8 2W3U_+KE%3;7&1:>4JGJAZN!W/ER*RG],;'XOUH==
M4O#OQOV',UK;Z6Q&K=4@PV4J6ZLY'MYV*L2J;78=O,H2<>W8D:GN5>0VL;N0
M%4QYM^"9' Y2FE@0 Z.BE<RVN+$C.VGOA(CN%+MV,O;LVZO_ +5(9AQX]'R2
M^$\ZUH[:8U1RJUN.7B/)U&1O83*C(Z_J/#<?,])93^XU.VO$'&9M8L-XU[#L
M4;0'DP;CJ8ZWC<C6X/:0PS*EM45N)9?1V)Z\K<?\&LG"Z?VI+&[&Y$A ^U^5
M[<1\M/CZTQ^<"D;1(]34V%;Z:;KLAI-NDN1EF\?9;M]746)C5"[31' [2$P!
M@BY+ZNHWLUT$D$GWPJ?3GFQ&/H#P2W2..Q';CCH0=]7[$Y'>.TJ4>5VMEE\6
M/#\>\ G$FZ</ H!9(Y5#26S70J&JRQ&9 HC%+'QAI18F/\M7%9WE.>]91^RF
M[V,UP+3VE%=$,-PMM"I@_P#C; *](0MXXR[;R*0F-<B!+]NH]C#S9$@4:G7(
M442(-7HR%8P/85P0@^)#VD#'V0K[@D]@1RI[D$@$ZT./Q9V7/M6_NNODE>MC
MHQZK'2=,.6BN2<K7Q\E)VZUL6)@8HI%+U7Z9)4G:&*61/-\>4(NJU(F-[&[-
MA\%0Z G[F7%::8I0D6-G%#\^SUP.* ZH>275JW,$$UL-,FT&YK14^#9''8TB
M]2(%I",1\IK+(HLV53SGZC$.@!XH7X(CZO?[0#\0!()Y+#2?A[2S65J1[PWE
M3HKG[[6Y<-&*44=[!;?OM'+!BGLA5FD#!?/59P;$"3O'(XDFL1"T#T^UIVCT
M:-'HT:/1HT>C1H]&C1Z-&CT:-'HT:/1HTJ/1W$7,?6DAJN3] 5:%L,G3QM\:
MB."F[E-HOH1;X3=@9(U:JHIR6*KO4!Q=:.%OO MP2%M?O+==@N48D6\U:"P8
MVF0.8R2O/MW]PP_.7D ])[$CN".0:KN/9.V=V6,79S^+AR,F(F>:H)2P1A(O
M#P640J+-5G6.9JTO5$TD2=:M&TL<F>V_S92%]08#6-KP =*JYC9027&0/! X
M"B&S@$R<#P[,K'8T4#"9 "&MG._W2,GVI..(N$6+W45]\'#W#;N2&*5!'(@9
M 00G)"]AP 0I ('R!Y'L>.0-/LOMO"9ZC!C,K0CM8ZM+%-%0\R>"F6@1HX4E
MKUI88K$$:L>BM826N&".(NN.-ES&NJFJVH FD:J>MX)6<>3PGC4) 8D!B K/
MRL9UTVW8@&#!LHIC&=OYBB>RF<[;;;;9VVVSGI(XXQTQHB+]$4*/Y !IYCL3
MB\1 *V*QM'&5QQ^(H5(*D7;L"4KQQJ3]I!/VZD#UWJ0T>C1I,_(#R>W[9Y.M
M3G?!4;'CDN9AB,.DI5LX<L8_+XN>&R(&^=:-,;N]&3I8<H&**M$UG.@@H0^2
MW<;YPBHVMU_4UY(>0"W!5B.0&4@@_7OQP>/D3JF[_P!J+O7:F4V\)8Z\]M(9
M*=F569*]NK/'8@=@G+A',9AE9 S"&63A6/PG7R@OV8Z11F.OY([[+>B;C'CG
M#Z"K0.!/04> 2UNAMN+5?2I:5[RAR/W=XT27?"! $DQ14V=-TG:B6&JL0N$8
M*6]3Q(!RG2A"AA[<MU=7'/S !'OW]M?/]'[F>S6K267WB\.8CC9Z+4*#P5X+
M:J3$7M&UZIHR_ 9X88)(P2RAR.DU3!.TO+K"K>>\=%I%,[IL^-2EW"5J>MFL
M(/T*<6,L-L:;[-B,^B4KD;L4HRU3*H'VY[4.Z *(G=GVXG=-YA@+.05_3%FD
M=6Z?+DC28\C[75B1QWY!X([\\=]97#O/Q:I9=]GRV;N:R=:T](X?+8REN&=I
MHSP2LE^I;LO$4 E%A9_)>N1/YAB(?5G_ )9KF[-X7?<\R*C*IK:D8E*N?Z_4
MM.RH;S91Y- 9T@L_DNL[CNLT4@\A81Y_A@B!7$LF;ALU=)_>74=<N\MGRC=[
M?DLU3"T<:1!H4\R18(CQ.>H.O44(!X"\#MV]OLT[Q7S&\MC/MZQ@\5C<)5M;
M?QYRN2I;;PDJQ[C,ED7Z_K31L1UW\L0-$B,JN.IJ[/TN5B3D+QH=:>7"HRG1
M79/6=Q@8N6?+MJ-921%W.&YK+-1=L:FC2'DCX$!'(@F]T5$"&T?;#'4A=HEG
MNK@>-:,5SG%>E8R$9FLV) I/XH,.OGZL%+*%7Y#C@D\GL .J)VCX:[L\6L3+
MN+>.[,Q!5FD9<(EE7NK-T%EFNI3DL5Z]>F).8H5KK$UAEF<-'&D;369>,;PA
MR'@WJ4]?,ZMV'6P*%0$Y%:TT#1HQ'#K([)W;!N6D9D>0=%&(S9M&&Q,(U;#C
MIC9UK(GNZRS;5DGAX]HXQJLYE>19 $*IP"I!8CEB#R!\/([$^^M*\,_!.QL3
M=$^>O9>GE8HJ$]7&B&M-7G2>TT:RV9HY'DCBZ:RRP*L<TW6+#DE.@==Q//7,
M,+YP_C#^$3,D+_Q@H#27Q('+-Q]Q'1O8WL(:-ONK-MG*VF9 1^^+^^C=?_LV
M&K!CA)7Y\C# L/5TECU$>_'8#GCV'VGG]7 &M@V]MBEMSUGI)K,WJS &]0R-
MT1UO/\E%Z47XAZB3K;LK?#TQQ\'J9/TOJR:\211J.2\0\C\L !)0!()_*?A)
M$*8FA#Y+/ZIO!I)!RR<I_P#R+([Z_P#3UX5##A@&!]P0"#^H]M(V*U>W"]>W
M7AM02#B2"Q%'-"X^CQR*R,/L92-*Q77!7*M-6XE=E+5<WIF:;HOFAQE5!Z2P
M* R]@]8O6>K"7U='2[&N#S8>L]V*B<NHOAP,,(-2#1=-5#'N@E2".3S8D\M^
M_/EEE1@01PT8/0>.>1\/8\'55QVP]K8;+#-87&+AKI5TG3%6+-"A<C='3R[F
M+KS)CIUC,AEBZJO5%,J2(P*C417+XI.+;PZ*K_IV5U@U86-#).E*Y$TCWW09
M$;:),4EE@ZMI1G#)5C(G0HSEF9R2;X'D3VS+03*W)\)M@<FE+0K2S).R<.K=
M3 <!9#\O,7CXN#WY[$^S<CMJ)S/A5LS-[BQ^Y[6,6/(TK0M6$K]$=3+2("83
ME*W04L-%-T3>8OER6.@0VVL0'RQ8_P"GNM&T>C1H]&C1Z-&CT:-'HT:/1HT>
MC1H]&C1Z-&CT:-'HT:/1HT>C1H]&C1Z-&CT:-'HT:I]J'_OINO?_ $JT=_\
MLM_4?'_A*S_\O#_2=9#A_P#CGW?_ ,U<'_733$^4G_N]>M?_ */2#_\ -KZ5
MO_WG9_T3:L/BC_Q>[N_^C6?_ -=3'QA_E Y9_P#3O3'_ /.X[Z4J_P![5_\
M01?]FNIC9G^*&UO^;V&__'U],MZ7U9='HT:/1HT>C1H]&C1Z-&CT:-'HT:/1
,HT>C1H]&C1Z-&O_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
